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1.1 Nanotechnology in Drug Delivery 
Nanotechnology represents not just one specific area, but a vast variety of 
disciplines controlling the shape and size at the nano-meter scale. One of the 
important areas of nanotechnology is “nanomedicine,” which refers to highly 
specific medical intervention at the molecular scale, for the diagnosis, prevention 
and treatment of diseases and/or disorders.1  
There is increasing optimism that performances in this field, such as the 
development of Nano Drug Delivery Systems (NDDS) that will bring significant 
advances in the diagnosis and treatment of disease, with the challenges to 
maximize therapeutic activity and to minimize undesirable side effects. 
If your drug use consists of an occasional aspirin, you may not see the need for 
serious work on drug delivery. However, if you were diabetic, having to inject 
insulin several times a day, or a cancer patient experiencing debilitating side 
effects from your treatment, the benefits of improved drug delivery could change 
your life.2 
Richard Feynman introduced the concept of nanotechnology as an important field 
for future scientific researches, during a lecture on December 1959 titled ‘‘There’s 
plenty of room at the bottom’’, concluding that nano-robots placed in the body 
may cure it at the molecular level.3  
Then, since emerging in the early 1970s, micro- and nano-scale intelligent and 
responsive delivery systems (designed to perform functions like detection, 
isolation and/or release of therapeutic agent) have attracted increasing attention: 
4,5 nanotechnology has finally entered in the field of drug delivery. 
With nanotechnology, scientists are acquiring abilities to understand and 
manipulate materials at the scale of atoms and molecules, with having the 
following key properties: the increased surface area and quantum effects.6,7 
Advantages of such nanostructures are relative to the ability to protect drugs, to 
delivery poorly-water soluble drugs, to increase their oral bioavailability due to 
their specialized uptake mechanisms and due to the ability to remain in the blood 
circulation for a long time (meaning a controlled release of the incorporate drug).  
Moreover, one of the most conspicuous achievements in the drug delivery field 
was the development of stimuli-sensitive delivery systems (SDDS), for which the 
rapid transitions of the physicochemical property of polymer systems are 
stimulus-dependent. This stimulus includes physical (temperature, mechanical 
stress, ultrasound, electricity, light), chemical (pH, ionic strength), or biological 
(enzymes, biomolecules) signals.  
These new SDDS have shown further advantages compared to conventional drug 
delivery systems: for the conventional DDS, the controlled release systems are 
based on the predetermined drug release rate independently of the 
environmental condition at the time of application. On the other hand, for the 
SDDS the release may be defined “on-demand”, allowing the drug carrier to 
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liberate a therapeutic drug only when is required, in response to a specific 
stimulation.8       
Basic prerequisites for design of new materials for appropriate carriers as drug 
delivery systems, involve knowledge on drug incorporation and release, 
formulation stability and shelf life, biocompatibility, biodistribution, targeting and 
functionality.  
In this respect, would be optimal develop biodegradable nanocarriers with life 
span limited as long as therapeutic effect is needed.9 Micelles, solid lipids 
nanoparticles, dendrimers, polymers, silicon or carbon materials and magnetic 
nanoparticles and nanohydrogels are some examples of nanosystems that have 
been tested as drug delivery systems. Furthermore, polymer-protein conjugates, 
polymer-drug conjugates, polymeric micelles and polymeric drugs, are often 
classified as NDDSs as well.10 
Use of smart drug delivery systems is a promising approach for developing 
intelligent therapeutic systems. 
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1.2 Nanohydrogels (NHs) as Drug Delivery Systems  
Even though nanomedicine is a relative new branch of science, many type of 
nanocarriers for drug delivery have been already developed over the past 30 
years. Among these, in our opinion, nanogels or nanohydrogels (NHs) deserve a 
special attention. 
 The term nanogels usually defines aqueous dispersions of hydrogel particles 
formed by physically or chemically cross-linked polymer networks of nanoscale 
size. The term “nanogel” (NanoGel™) was first introduced from Kabanov and 
Vinogradov to define cross-linked bifunctional networks of a polyion and a non-
ionic polymer initially designed for delivery of antisense oligonucleotides (cross-
linked polyethyleneimine (PEI) and poly(ethylene glycol) (PEG) or PEG-cl-PEI). 1, 2 
However, prior to this, the group of Akiyoshi et al. described the phenomenon of 
physical cross-linking (self-assembly) of cholesterol-modified polysaccharides (e.g., 
pullulan, mannan, amilopectin and dextran), which resulted in formation of 
swollen hydrogels at nanoscale size.3 
Nanogels or nanohydrogels (NHs) are nanoscalar 3D polymer networks, with a 
tendency to absorb water when placed in an aqueous environment. Their affinity 
to aqueous solutions, superior colloidal stability, inertness in the blood stream 
and the internal aqueous environment (suitable for bulky drugs incorporation) 
make them ideal candidates for uptake and delivery of proteins, peptides, and 
other biological compounds.  
 
Figure 1. Molecular self-assembly of amphiphilic polymer in water, thus forming NHs. 
 
Nanogels are superior drug delivery system than others due to their molecular 
size (ranging between 100- 700 nm), resulting in easy escape of renal clearance 
and in prolonged serum half-life period, allowing both passive and active drug 
targeting. Moreover, the drug release can be controlled and sustained at the 
target site, improving the therapeutic efficacy and reducing side effects. A typical 
advantage of these hydrogel nanoparticles, respect to other nanoparticles, is the 
possibility of obtain an elevated degree of encapsulation and offer an ideal 
tridimensional microenvironment for many macromolecule types, which may be 
encapsulated without chemical reactions: this is an important factor for 
preserving the drug activity. Furthermore, it is notable their ability to reach the 
Amphiphilc polymer 
Water 
Self-assembly 
Nanohydrogel (NHs) 
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smallest capillary vessels, due to their tiny volume, and to penetrate the tissues 
either through the paracellular or the transcellular pathways. 4-7 
The design and development of NHs as functional smart materials for 
biotechnological and biomedical applications have attracted curiosity because of 
their unique properties that combine the characteristics of hydrogel systems with 
a very small size. Due their inherent rapid swelling and de-swelling nature in 
response to external stimuli such as solvent composition, light, temperature, pH, 
pressure, magnetic and electric fields, indeed NHs may be designed to be stimuli-
responsive, in order to alter the cross-linking or the swelling behavior in specific 
conditions. 8-11 
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1.2.1 Synthesis and classification of NHs  
Nanohydrogels are commonly classified into two major groups. The first 
classification is based on their responsive behavior, from which they can result 
either stimuli-responsive (swell or de-swell upon exposure to environmental 
changes) or non-responsive (simply swell as result of absorbing water). The 
second classification is based on the type of linkages present in the polymers 
network, resulting from the approaches used for their preparation. 
 Current approaches used for NHs preparation are the followings: i) physical self-
assembly of interactive polymers; ii) polymerization of monomers in 
homogeneous phase or micro- or nano-heterogeneous environment; iii) chemical 
cross-linking of the polymer chains using a bi-functional cross-linking agent and iv) 
other synthetic techniques based on the template-assisted nanofabrication of 
nanogels particles.12 
 
 
 
Figure 2. Typical approaches used to prepare NHs: a) Physically cross-linked NHs through non-
covalent interactions; b) Chemically or physically cross-linked NHs using preformed polymers; c) 
Chemical cross-linked NHs by bi-functional cross-linker and a polymer. 
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An example of physical cross-linked NHs were developed from Akiyoshi et al. They 
prepared hydrogels nanoparticles by hydrophobic association of cholesterol-
modified pullulan in presence of insulin,13 due the advantages that physical 
interactions (such as van der Waals forces, hydrophobic, electrostatic interactions, 
or hydrogen bonding) of amphiphilic block copolymers and/or complexation of 
oppositely charged polymeric chains results in the formation of micro- and 
nanogels in only a few minutes. Moreover, self-association of hydrophilic 
polymers allow encapsulation of biomacromolecules while NHs are forming.  The 
sizes of self-assembled nanogels in general are controlled by proper selection of 
the concentration of polymers and environmental parameters. In this respect, Yu 
et al.  also prepared protein nanogels by temperature-induced gelation of 
oppositely charged proteins;14 furthermore, in 2008, M. J. Alonso and 
collaborators developed the first hyaluronan-chitosan NHs, using an ionotropic 
gelation process.15 
Chemical NHs are comprised of permanent chemical linkages (covalent bonds) 
throughout the polymer networks, instead. The properties of the resulting cross-
linked NHs depend on the chemical linkages and functional groups present in the 
networks. Different nanogels have been synthesized using different chemical 
reactions strategies. Currently, various chemical cross-linking reactions have been 
developed, including the activating agent mediated amide bond cross-linking, 
quaternisation of amino groups,16 “click” chemistry,17and photo-cross-linking 
technique.18 These crosslinking points allow modifying entire physicochemical 
properties of the NHs systems. 
Moreover, many studies used one of the basic procedures described above to 
prepare increasingly sophisticated types of nanogels.  
Several polymers can be used to achieve NHs: typical natural polymers such as 
polysaccharides, that show a higher biocompatibility and biodegradability in 
comparison to synthetic polymers.19 The most used polysaccharides used on this 
purpose are hyaluronan, pullulan, chitosan, alginate, dextran and mannan. On the 
other hand, poly(lactic-glycolic acid), poly(caprolactone), poly(N-
isopropylacrylamide) and poly(lactic acid) represent examples of synthetic 
polymers capable to form NHs’ networks. 
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1.2.2 Polysaccharide based-NHs 
Nowadays, polysaccharide-based nanoparticles have been proposed for 
innovative DDSs due to their unique multi-functional groups in addition to their 
physicochemical properties, in particular their marked biocompatibility and 
biodegradability.20-22  
Polysaccharides are a class of biopolymers formed of multiple monosaccharide 
repeating units joined together through glycosidic linkages. The multi-functional 
groups of the polysaccharide backbone, a wide range of molecular weights, their 
abundance in nature, and their varying chemical composition (which all contribute 
to their diversity in structure and properties), make polysaccharide the most 
attractive and promising biomaterial in nanomedicine investigations. 23-25 In 
general, hydroxyl, amino, and carboxylic acid are the reactive functional groups on 
polysaccharides backbone, which can be easily modified by usual synthetic 
methodologies. 
The main methodologies for polysaccharide modifications are ester and ether 
formation using sugars hydroxyl group as the nucleophiles. In this respect, K. 
Akiyoshi and co-workers developed the first self-assembled polysaccharide NHs 
based on cholesterol-bearing pullulan derivative obtained by esterification,3 or 
the self-assembled nanogel derived from an acid-labile cholesteryl-modified 
pullulan, prepared by grafting vinyl ether-cholesterol substituents onto a 100 kDa 
pullulan.26  
Chemical oxidation of primary alcohols to aldehyde and carboxylic acids,27-29 
enzymatic oxidation of primary alcohols to uronic acid,30 formation of amide 
bonds between saccharides carboxyl group and heteroatomic nucleophiles using 
coupling agents (e.g. EDC/NHS, DCC/DMAP)31-33 and nucleophilic reactions of the 
amines of some polysaccharide (e.g. chitosan)34 are further chemical modification 
extensively investigated.  
Among the numerous techniques, polysaccharide-based NHs can be obtained 
through chemical or physical cross-linking, polyelectrolyte complexation and self-
assembling of hydrophobic-modified polysaccharides. Compared with covalent 
cross-linking, the physical cross-linking shows more advantages such as mild 
preparation conditions and quite simpler procedures. 
The functionalization of hydrophilic polysaccharides with hydrophobic molecules, 
based on the synthetic strategies described above, allows the formation of 
amphiphilic polymer chains that, upon contact with an aqueous environment, 
spontaneously form close nanostructures via intra- or intermolecular associations 
between hydrophobic moieties, in order to minimize the interfacial free energy. 
Moreover, sizes of such nanostructures can be modulate depending on the 
structural properties of the resulting modify-polysaccharides, the kind of 
functionalization strategy chosen, the degree of functionalization of the main 
chain, and the MW of the polymer as well.  
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Based on the same considerations, naturally-derived nanohydrogels have been 
prepared from polysaccharide such as chitosan, hyaluronic acid, heparin, 
chondroitin sulfate, agarose, and alginate.  
For instance, chitosan-based NHs have been developed by M. J. Alonso and 
collaborators; the preparation of this nano-system was based on the ability of 
chitosan to undergo a sol-gel transition due to the ionic interaction with poly-
anions, such as tripolyphosphate (TPP).35 
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Figure 3.  Chemical structures of polysaccharides typically used for NHs preparation. 
 
Alginate was used as well from Xue et al. to develop a one-pot method for the 
preparation of pH-responsive doxorubicin-loaded nanogels.36 
In recent years, our group developed two different hyaluronan based NHs, formed 
by self-assembly. These nano-carriers effectively showed the ability to conjugate 
proteins and retain their activity after the immobilization.37,38 
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1.2.2.1 Hyaluronic acid (HA) based NHs for drug delivery 
Hyaluronic acid (HA), an immune-neutral polysaccharide that is ubiquitous in the 
human body, is strategic for many cellular and tissue functions and has been in 
clinical use for over three decades.39  
HA was first isolated in 1934 from bovine vitreous humor by Meyer and Palmer.40  
The name “hyaluronic acid” was coined by them as a conjugation of two words, 
hyaloid (vitreous) and uronic acid (one of the two sugar molecules from which this 
new substance was composed). Then, Karl Meyer and his collaborators figured 
out the chemical structure of hyaluronic acid in the 1950s: 41 HA, or hyaluronan, is 
a linear hetero polysaccharide that consists of alternating units of a repeating 
disaccharide: β-1,4-D-glucuronic acid – β-1,3-N-acetyl-D-glucosamine. HA is a non-
sulfated glycosaminoglycan, and is synthesized in the plasma membrane of 
fibroblasts and other cells by addition of sugars to the reducing end of the 
polymer, whereas the nonreducing-end protrudes into the pericellular space.42 
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Figure 4. Chemical structure of HA repetitive unit 
 
In physiological conditions, HA is in the form of sodium salt, therefore (HA-NA+) 
referred to as sodium hyaluronate. HA exists as a poly-anion in vivo and in this 
form it is highly hydrophilic and surrounded by a sphere of water molecules linked 
by hydrogen bonds.  
Observing its chemical structure (Figure 4), it is evident that HA can be chemically 
modified due to its multi-functional groups such as the carboxylic acid of 
glucuronic acid, primary and secondary hydroxyl groups and the N-acetyl groups. 
The modifications aimed at enhance, modulate or control the therapeutic action 
of HA and develop new products (with alerted properties, including its 
hydrophobicity and biological activity). 
Numerous chemical modifications have been described in the literature, which 
are reviewed by C.E. Schanté et al. These are performed in different solvents (to 
modify HA with hydrophobic molecules the organic media is necessary and, due 
to the poor solubility of HA in organic solvents, the tetrabutylammonium salt of 
HA is required43), target different sites on HA and yield different results in terms 
of modification efficacy and chain length damage. The method should be chosen 
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carefully, based on the starting material and final product characteristics 
desired.44 
The most widely method of modification of the carboxylic group of HA is the 
amidation with carbodiimides.45  Nevertheless, P. Farkas et al. showed that 
triazine-based reagent (in particular 4-(4,6-dimethoxy-1,3,5- triazin-2-yl)-4-
methylmorpholinium (DMTMM)), was a more efficient as activator of carboxylic 
groups than carbodiimides, leading to higher functionalization degree of the 
products, and higher degree of purity.46, 47  
Laurent, Hellsing, and Gelotte were the first to report HA crosslinking in the far 
1964,48 based on the observation that divinyl sulfone (DVS) reacts readily with HA 
in aqueous alkaline solutions at room temperature, i.e., about 20° C., thereby 
providing cross-linked HA gels. Today, the hydroxyl groups are commonly 
modified by etherification, esterification and cross-linking by using divinyl sulfone 
or epoxides. Modifications of the N-acetyl groups are usually performed after 
deacetylation. Bellini and Topai patented the amidation of HA by reaction of an 
acid with the deacetylated amino-group of HA.49 
Moreover, a nearly recent methodology to prepare HA derivatives is composed by 
orthogonal chemistry in a simple one-step reaction based on Huisgen 
cycloaddition, which is a “click”-type reaction, highly selective, and free from side 
reactions and by-products.50-52 
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Figure 5. Examples of chemical modifications of HA: A) Huisgen cycloaddition (“click”-type reaction) 
of azid-dervative of Riboflavin tetrabutyrate and alkyl-derivative of HA (HA-c-Rfv); 
B) esterification of the carboxylic group of HA with a bromide derivative of Cholesterol (HA-CH); C) 
HA amidation with adipic dihydrazide by with EDC/NHS and EDC/HOBt (HA-ADH);  
D) etherification of HA hydroxyl group with methacrylic anhydride (HA-MA).     
Chapter 1  
20 
 
The resulting HA derivatives can be classified in to two primary categories: the 
“monolithic” that is the terminally modified forms of HA that cannot form new 
chemical bonds, and the “living” derivatives that can form new covalent bonds, 
allowing consecutive cross-linking or attachment of therapeutic 
drugs/polypeptides to HA.53, 54 
Overall, the so evidenced versatility in HA macromer synthesis and processing of 
the materials has transitioned into materials with a range of properties useful in 
applications such as tissue engineering and drug delivery. Nowadays numerous 
researchers investigated the application of HA based nanogels in DDS. First, the 
arrangement of HA polymeric chains in these 3D soft nanomatrices reduce the HA 
clearance from the blood, thus the reduction of the degradation of HA by 
hyaluronidase due the modification of the chemical structure of the polymer 
chains. Moreover, it has been demonstrate that HA based nanoparticles can 
efficiently accumulate in cancer tissues (whereas native HA is quickly cleared from 
the body).55, 56  This might result from the increased circulation time and EPR 
effect as well as tumor selective binding of HA to CD44 receptor. The binding of 
HA with CD44 receptors, provides not only a targeting to certain tumor cells, but 
also allows HA to diffuse through the cell membrane and enter into the 
intracellular microenvironment.57  This peculiarity marks the extremely useful 
strategy to deliver certain drugs intracellularly by HA-based nanogels (for instance 
drugs that would not otherwise pass through the cell membrane, due to their 
physico-chemical properties).  
Additionally, HA demonstrated the ability to interact with several proteins inside 
the body.58 This evidence gave the idea to develop useful HA-based nanocarriers 
to conjugate proteins, challenging the preservation of their activity and increment 
of their stability and availability in human tissues.59 
In general, the production of nanostructured materials from hyaluronic acid can 
fit many properties of nano-scale drug delivery systems for specific applications: 
solubility (inherent hydrophilicity of HA), biodistribution (targeting to cancer 
cells), biocompatibility (electrical charge), biodegradability (binding/ crosslinking 
density) and drug release (HA-drug spacer or physical interaction between a drug 
and a carrier).  
On this purpose, several kinds of HA-based nano-carriers, such as HA-drug 
conjugates, HA-based nanocomplexes, HA-coated nucleic acid/polycation, HA-
decorated nanoparticles and HA-based NHs were designed.60   
In particular, HA-based NHs are classified by the type of crosslinks from which are 
formed.56  
The most common and interesting strategy used to form such NHs is the physical 
crosslinking from non-covalent attractive forces between the polymer chains, 
which were previously partially modified with hydrophobic moieties. Based on 
this, hydrophobic molecules and/or hydrophobic long chains have been grafted to 
HA to form, in aqueous media, self-assembled NHs with internal hydrophobic 
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domains: 5β-cholanic acid,61 cholesterol,59 2’3’4’5’-tetrabutyrilriboflavin,38 PLGA61 
and PEG-PCL62 are few examples of hydrophobic moieties linked to the selected 
polysaccharide, aiming the purpose to form smart nanocarriers. However, the HA 
poly-anionic nature represents a limitation in encapsulating negatively charged 
macromolecules such as siRNA and DNA. 
Chemically cross-linked NHs are usually more stable than the physically cross-
linked analogues. However, the synthetic strategies that can achieve this are 
normally based on phase separation, such as the inverse water-in-oil (w/o) 
microemulsion method,63 or the oil-in-water type emulsion.64 However, these 
techniques generally require high energy sources and hard conditions that may 
limit the entrapment of delicate molecules such as peptides and proteins. 
Moreover, the permanent cross-linkages may result in a reduced therapeutic 
efficacy, due the inhibition of drug release at the target site. Nevertheless, 
degradable linkages have been used to obtain chemically cross-linked stimuli-
responsive NHs. For instance, H. S. Han and colleagues developed NHs based on 
an amphiphilic HA-polycaprolactone block copolymer, coupled via a bio reducible 
di-sulfide linkage (cleavable in the cytosol by glutathione (GSH)): this strategy 
allowed the controlled release of drugs inside the cells, increasing the HA NHs’ 
stability in the blood circulation.65 
HA has also the property to form nanogels via ionotropic gelation, which relative 
to the ability of polyelectrolytes to cross-link in the presence of counter ions.66  On 
this purpose, Jain et al. synthesized HA coupled chitosan nanoparticles (HACTNPs) 
carrying 5-flurouracil (5FU) by ionotropic gelation methods, for the effective 
delivery of drug to the colon tumors.67 
Nevertheless, the current limitation of the HA targeting nanocarriers is their high 
accumulation in the liver and spleen, because HA molecules expose the 
nanocarriers to the HA receptors identified in these organs. 
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1.3 Polymeric micelles as Drug Delivery Systems  
Though much progress has been made in drug delivery systems, the design of a 
suitable carrier for the delivery of hydrophobic drugs is still a major challenge for 
researchers. Recently, colloidal carrier systems have been receiving much 
attention in the field of drug targeting because of their high loading capacity for 
drugs as well as their unique disposition characteristics in the body. Amongst 
these carrier systems, micellar particles consisting  of amphiphilic molecules is an 
effective way of delivery drugs to their targets. 
   Micelles are self-assembling nanosized colloidal particles with a hydrophobic 
core and hydrophilic shell and are currently successfully used as pharmaceutical 
carriers and they have demonstrated a series of attractive properties as drug 
carriers.1 Among the micelle-forming compounds, amphiphilic copolymers (i.e. 
polymers consisting of hydrophobic and hydrophilic blocks) are gaining  increasing 
attention.  
Block copolymers with amphiphilic character have large solubility differences 
between the segments. If the length of a hydrophilic block is too high, copolymers 
exist in water as unimers (individual molecules), while molecules with a very long 
hydrophobic block form structures with non-micellar morphology, such as rods 
and lamellae.2  When the block-copolymers consist of a good 
hydrophobicity/hydrophilicity balance, together with their molecular weight, the 
length of the hydrophobic block, and chemical characteristics of the blocks (in 
terms of their chemical nature),  is known that they assemble, in an aqueous 
media, into polymeric micelles with a mesoscopic size range.3-7 Generally, these 
micelles have a fairly narrow size distribution and are characterized by the core–
shell architecture, where hydrophobic segments constitute the inner core 
surrounded by a barrier of hydrophilic segments. The hydrophobic part provides 
an environment for the encapsulation of hydrophobic drugs, protein or DNA 
through physical or chemical binding modes. The hydrophilic part of the polymeric 
micelles is important due to its brush like architecture, which allows the 
hydrophilic part to protect the hydrophobic part from the biological invasion, such 
as the minimization of plasmatic protein adsorption (i.e., meaning an increasing of 
the renal clearance).8 
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Polymeric micelles belong to a group of association or amphiphilic colloids, which 
form spontaneously under certain concentration called the critical micelle 
concentration (CMC). At concentrations lower than the specific CMC, in an 
aqueous medium such amphiphilic molecules exist separately. Moreover, as their 
concentration is increased, aggregation takes place within a rather narrow 
concentration interval.1 
 
 
Figure 6. Formation of polymeric micelles by self-assembly of amphiphilic block copolymers in water 
above their CMC. 
 
The process of micelle formation involves the decrease of free energy in the 
system: while micelles are forming, the hydrophobic fragments are separated 
from the aqueous environment and hydrogen bonds are simultaneous re-
established in the water network. Additionally, at same time, the Van der Waals 
bonds between hydrophobic blocks in the core of the formed micelles result in 
energy gain.9, 10 
   The use of micelles as drug carriers provide a set of clear advantages: increased 
water solubility of poorly-water soluble drugs and its improved bioavailability, 
reduction of toxicity and other adverse effects, enhanced permeability across the 
physiological barriers, and substantial and favorable changes in drug 
biodistribution. Moreover, the use of micellar particles with specific shell 
properties can also enhance blood circulation time.3 
Recently, interest has been raised in the application of these block copolymer 
micelles as novel systems in the field of drug targeting because of the high drug-
loading capacity of the inner core as well as of the unique disposition 
characteristics in the body.11, 12 
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1.3.1 Synthesis and Classification of Polymeric Micelles 
Block copolymer micelles can be classified according to the type of intermolecular 
forces driving the separation of the core segment from the aqueous media. Based 
on this, in the past few decades, at least three main categories were identified: 
amphiphilic micelles formed by hydrophobic interactions, polyion complex 
micelles (PICM) resulting from electrostatic interactions, and micelles stemming 
from metal complexation.13-15  
   In the drug delivery field, most amphiphilic copolymers employed to form 
micelles by self-assembly of non-polar and hydrophobic interactions, generally 
contain either a polyester or a poly(amino acid) derivative as the hydrophobic 
segment. Poly(lactic acid) (PLA),16-18 poly(-caprolactone) (PCL),19-21 and 
poly(glycolic acid)22,23 are all biocompatible and biodegradable polyesters  
commonly used for micelle preparation aimed for biomedical application in 
humans. Many amphiphilic micelle-forming unimers include poly(ethylene glycol) 
(PEG) blocks as hydrophilic corona-forming blocks.24 This polymer is inexpensive, 
has a low toxicity, and serves as an efficient steric protector of various biologically 
active macromolecules25-29and particulate delivery systems.30-32 Moreover, 
numerous studies have confirmed its ability to reduce mononuclear phagocytic 
system (MPS) uptake of micellar delivery systems.33 
   The self-assembly of polyion complex micelles (PICM), proceeds through the 
neutralization and segregation of oppositely charged polyions in a way that 
combines features of amphiphilic micelles and interpolyelectrolyte complexes, 
instead. On this purpose, K. Kataoka and his collaborators prepared lactose 
conjugated polyion complex micelles that at physiological pH may be considered 
good candidates for incorporation of polyanionic plasmid DNA.34   
 
 
Figure 7. Characteristics of polymeric micelles that are relevant for drug delivery. 
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To better predict and control the properties of a micellar system, the utilized 
copolymer has to be well-defined, in terms of the nature of the polymer and the 
most appropriate polymerization reaction used. In general, micelle-forming 
amphiphilic copolymers can be either block copolymers (di, tri, or tetra) or graft 
copolymers, resulting in different final shapes/forms .35 
   Currently, a few commonly applied strategies of drug-loading procedures have 
been reported to form micelles . The first one is mostly employed for moderately 
hydrophobic copolymers, such as poloxamers, based on the direct dissolution of 
the block copolymer along with the drug in an aqueous solvent. Different 
strategies are used with amphiphilic copolymers that are not readily soluble in 
water and for which an organic solvent is used. In this case, the mechanism of 
micelle formation depends on the solvent-removal procedure: dialysis against 
water, for water miscible solvents; or solution-casting method for the non-water 
miscible ones.36 On this respect, interestingly was the preparation of 
nanoparticles by nanoprecipitation of methacrylic acid copolymer (Eudragit L 100-
55) with poly(vinyl alcohol) as a surfactant from which it was evidenced that the 
mean particle size was clearly dependent on the compatibility of the solvent with 
water.37 
   Among the multiple block copolymers already designed , recently, block 
copolymers containing thermosensitive elements have been used for the design 
and synthesis of smart drug-loaded polymer micelles, which dissociate in 
response to the range of environmental changes (i.e. change in temperature).41-46  
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1.3.2 Thermosensitive Micelles 
For ideal drug targeting, the drug should be released only after the polymeric 
micelles accumulate at the targeted tissue, by some trigger such as changes in pH, 
presence of specific enzymes, etc. or by an external effect including temperature, 
light, ultrasound or magnetic field. The result of stimulation by either 
physiological or external trigger is the destabilization of micelles, termed as 
'stimuli-sensitivity' of the micelles.38 Depending on the stimulus applied varying 
responses may be observed including disruption of the structure, changes in 
shape, volume, permeation rates, hydration state, swelling/collapsing, or 
conformational changes. 
 
 
Figure 8. Examples of stimuli-sensitive polymeric micelle destabilization. A) poly(L-histidine)–
poly(ethylene glycol) (PEG-b-p(L-His)) diblock copolymer based  pH-sensitive micelle;70 B) high-
frequency ultrasound-responsive poly(ethylene oxide) and poly(2-tetrahydropyranyl methacrylate) 
(PEO-b-p(THPMA)) block copolymer based micelle;71  C) block copolymer of poly(N-(2-
hydroxypropyl) methacrylamide lactate) and poly(ethylene glycol) (PEG-b-pHPMAmDL) 
thermosensitive and biodegradable polymeric micelles;72 D) synthetic micelle sensitive to IR light of 
poly(ethylene glycol) as the hydrophilic component and 2-diazo-1,2-naphthoquinone as the 
hydrophobic component (PEG-b-pDNQ).73  
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An important class of stimuli-responsive micelles are those comprising polymers 
with thermosensitive behavior. Thermoresponsive polymers are a class of “smart” 
materials that have the ability to respond to a change in temperature: a property 
that makes them useful materials in a wide range of applications. In particular, the 
nanocarriers accumulate in the required sites through either passive or active 
targeting, and when they reach the maximum accumulation, the carried drugs are 
released in a rapid manner, in response to changes in the environmental 
temperature, i.e. by hypo- or hyperthermia.39-41 
Guilet and collaborators were the first to investigate, in 1985, the influence of 
temperature on flocculation process of this kind of polymers. They observed that 
certain temperature-sensitive polymers are effective flocculants below their 
transition temperature only.42 However, other researchers found temperature-
responsive polymers to act as flocculants above their transition temperature as 
well. Aqueous solutions of thermoresponsive polymers can exhibit two main types 
of phenomena: a lower critical solution temperature (LCST) or an upper critical 
solution temperature (UCST). LCST and UCST are the respective critical 
temperature values below and above which the polymer and solvent are 
completely miscible.43 
The explanation of these phenomena is based on what phase dispositions are 
energetically (free energy) more favorable. Specifically, the main driving force is 
the entropy of  water molecules, which is higher when the polymer is not 
dissolved .44 It is remarkable that LCST is an entropically driven effect, while UCST 
is an enthalpically driven effect.45 
 
 
Figure 9. LCST behavior of thermosensitive polymers. Below the LCST, the polymer is water-soluble 
and in expanded state, above their LCST the hydrogen bonds between the polymer chains and the 
molecules of water are disrupted, and the polymer collapsed. 
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Well-known thermosensitive polymers are poly(N-isopropylacrylamide) 
(pNIPAAm) and Pluronics (PEG-b-PPO-b-PEG), a triblock copolymer of 
polypropylene oxide [PPO] middle block flanked by polyethylene glycol [PEG] 
blocks, applied in controlled drug delivery due to its properties of temperature 
responsive micellization and gelation.46 Other polymers with thermoresponsive 
properties include poly(N,N-diethylacrylamide) (PDEAAm) with an LCST over the 
range of 25 to 32 °C and poly(N-vinlycaprolactam) (PVCL) with an LCST between 
25 and 35 °C.47,48 
San Miguel et al. synthesized ABA triblock copolymers of poly[2-
(dimethylamino)ethyl methacrylate] (PDMAEMA, with an LCST of around 50 °C) as 
block A, and PVCL as block B, and demonstrated the formation of 
thermoresponsive micelles with sustained drug release in vitro.49  
Moreover, poly(ethylene glycol) (PEG), also called poly(ethylene oxide) (PEO) has 
shown thermosensitive properties, with LCST values around 85 °C.50,51 
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Figure 10. Chemical structures of thermosensitive polymers commonly used for micelle preparation. 
 
It should be noted that the LCST is affected by the hydrophobiticy of the side 
groups. Specifically, the LCST of a polymer is often also dependent on molecular 
weight and architecture.52,53 
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1.3.2.1 Thermosensitive Polymeric Micelles based on 
poly(N-isopropylacrylamide) p(NIPAAm)   
One of the most extensively investigated thermosensitive polymers is pNIPAAm. 
This polymer has an LCST of 32°C in aqueous environment, which means that it is 
water-soluble below this temperature and water-insoluble above this 
temperature. pNIPAAm is the most widely used thermosensitive polymer because 
of its phase transition temperature near  physiological temperature. In 1998, 
Chung et al. showed the effect of linking different moieties to the terminal end of 
a pNIPAAm, concluding that the LCST dramatically change depending on the 
nature of the end moieties.54  More specifically, hydrophilic end-groups raised the 
LCST and the inverse was noticed when hydrophobic moieties were used. 
Moreover, as result of these LCST changes, micelles formed from those 
copolymers, may have the pNIPAAm block either as hydrophilic shell or as 
hydrophobic core. For this purpose, Leroux and collaborators prepared polymeric 
micelles based on poly(N-isopropylacryamide-co-methacrylic acid-co- octadecyl 
acrylate) (p(NIPAAm-co-MAA-co-ODA)) random copolymer with NIPAAm and MAA 
segments constructing the shell and ODA segments forming the core. The 
incorporation of a small amount of hydrophilic MAA units to the polymer chains 
increased the LCST of the resulting copolymer to 37°C.  Moreover, due the MMA 
units copolymerized in the polymer backbone, the resulting amphiphilic polymer 
showed also pH-sensitive characteristics.55  
T. Okano and other groups prepared other micelles with thermosensitive outer 
shell type, which were composed of thermosensitive p(NIPAAm) blocks as the 
outer hydrophilic shell and hydrophobic poly(butylmethacrylate) (PBMA)56 or 
poly(D,L-lactide) (PLA)57 as the drug-incorporated inner core.  
   On the other hand, pNIPAAm-b-PEG is the most studied polymer to prepare 
micelles with pNIPAAm as core-forming segments. In this case, the highly 
hydrated hydrophilic PEG chain is used for the stabilization of dispersions. Below 
the LCST of pNIPAAm block, pNIPAAm-b-PEG is highly soluble in aqueous solution, 
while above the LCST, the thermo-sensitive pNIPAAm block precipitates, and the 
block copolymers self-assemble into polymeric micelles with a pNIPAAm core and 
a hydrophilic PEG shell.58 For example, Tenhu and co-workers studied the 
aggregation of pNIPAAm-b-PEG in water by fluorescence spectroscopy and light 
scattering.59  
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Hennink et al. developed degradable copolymers of poly(NIPAAm-co-poly(N-(2-
hydroxypropyl) methacrylamide-lactate) polymerized with PEG. In this case, due 
the higher hydrophilicity of the PEG block, the p(NIPAAm-co-HPMAm-lactate) 
block constituted the inner hydrophobic core of the obtained micelle. Moreover, 
in this work, the cleavage of the lactate moiety in vitro or in vivo causes an 
increase in the polymer LCST and ultimately destabilization of the micelles, 
releasing any encapsulated drug.60 
 
 
 
 
Figure 11. pNIPAAm based micelle with pNIPAAm as hydrophilic shell (p(PBA)-b-p(NIPAAm) or as 
hydrophobic core (PEG-b-p(NIPAAm). 
   The formation of micelles in solution is a reversible and dynamic process: the 
resulting dissociation can lead to premature release of a loaded drug. Crosslinking 
of the polymer chains can overcome this once micellization has occurred; this 
reaction can be done in the core or in the shell of micelles. 
Redox-sensitive core crosslinked pNIPAM based micelles were reported by Narain 
et al. The resulting micelles exhibited reversible swelling behavior within a 
temperature range of 28-32 °C.61 
Wei et al. produced a number of shell crosslinked hybrid micelles using inorganic 
ferric-based crosslinks and pNIPAAm thermoresponsive groups. They found drug 
release to be sustained for around 100 hours followed by a slow leveling-off of the 
release rate.62,63 However, chemical conjugation methods are not always feasible, 
due the toxicity of some crosslinking agents and due some side reactions that can 
happen during the process that might affect the therapeutic properties of 
conjugated drugs. Alternatively, physical interactions, such as π−π stacking,64,67 
hydrogen bonding68 or stereocomplex formation69 have been investigated to 
improve the thermodynamic and kinetic stability of such polymeric micelles. 
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1.4 “Click Chemistry” as chemistry of Nanomaterial 
A close examination of nature’s favorite molecules, such as nucleic acids and 
proteins, reveals an overall preference for making carbon-heteroatom bonds over 
carbon-carbon bonds. Inspired by nature, and limiting the search for new 
substances to those that can be generated by joining small units together through 
heteroatom links, Sharpless et al. defined “click chemistry” as reactions that ‘‘are 
modular, wide in scope, high yielding, create only inoffensive by-products (that can 
be removed without chromatography), are stereospecific, simple to perform and 
that require benign or easily removed solvent’’.1 
A wide range of click chemistry reactions include cycloaddition reactions, such as 
the 1,3-dipolar family, and hetero Diels- Alder reactions;2 carbonyl chemistry, such 
as the formation of oxime ethers, hydrazones, and aromatic heterocycles;3, 4 
nucleophilic ring-opening reactions (e.g., epoxides, aziridines, cyclic sulfates, and 
so forth);1 and azide-phosphine coupling (Staudinger ligation).5, 6 
The most popular click reaction is the 1,3-dipolar azide-alkyne cycloaddition 
reaction, first discovered by Hüisgen in 1963, but it did not attract much interest 
due to the requirements of high temperatures and pressures.7  Rostovtsev et al. 
and Mendal et collaborators demonstrated that the reaction could also be carried 
out under mild conditions using Cu(I) as the catalyst, and with great regio-
selectivity on obtain 1,4-disubstituted 1,2,3-triazole product preparing the catalyst 
in situ by reducing copper(II) salts with a reducing agent (i.e. CuSO4 5H2O, sodium 
ascorbate).8, 9 
N-
N+
N
Cu(I)
N
N
N
Click Reaction
 
Figure 12. Copper(I)-catalyzed Azide-Alkyne Cycloaddition (CuAAC), well known as Hüisgen click 
chemistry reaction. 
Moreover, Codelli et al. reported an alternative method to lower the activation 
barrier for the cycloaddition by employing intrinsically highly strained cyclic 
alkynes that readily and selectively react with azides, and do not need Cu(I) as 
catalyst of the reaction. These new ‘click chemistry-Copper free’ products form at 
ambient temperature and pressure with no apparent cytotoxicity.10, 11 
Another widely used click chemistry reaction was reported by Staudinger and 
Meyer in 1919 named the ‘Staudinger ligation’, which forms phosphazo 
compounds by reacting tertiary phosphines with organic azides.5, 6 
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Even though, more click chemistry strategies have been developed.12-16  In 
general, the concept of click chemistry therefore represents a highly valuable 
contribution to effect a ‘universal’ modification strategy that has the ability not 
only to generate novel structures, but also to simplify the covalent assembly of 
very chemically dissimilar molecules, such as complex carbohydrates with 
peptides, or chemo reporters, such as fluorescent dyes with biopolymers. This 
highly selective, specific chemistry has emerged as an attractive technique to 
conjugate easily materials for several applications. As result, numerous 
biomolecules including DNA, peptides, proteins, oligosaccharides and 
glycoconjugates have been labelled with various appendages. 
Although, significant efforts have been made in formulating macromolecule based 
nanocarriers using the variety of synthetic click chemistry strategies above 
mentioned, as mild reaction conditions, high yield, simple work-up, selectivity, 
and specificity; due to its fulfilling of many requirements for the affixation of 
ligands onto i.e. polymers by pre- or post-modification processes. In this respect, 
Adronov et al. used click chemistry to functionalize single-walled carbon 
nanotubes with polystyrene, in order to increase their water solubility. The ‘click 
reaction’ was mediated by incorporation of a small alkyne bearing reactive species 
on to the surface of the nanotube, followed by coupling of these fragments to 
terminal azide bearing polystyrene chains.17 Additionally, Goyal, Yoon, and Weck 
worked on development of poly(amine) dendrimer that possessed a aldehyde or 
azide moiety on the dendrimer surface capable of orthogonal functionalization 
with small molecule functional groups by click chemistry.18 
Moreover, a wide range of polymer functionalization strategies were used to 
speed up the use of polymers with defined functional ligands, positioned in either 
the main chain or the respective side chains. For instance, Haddleton and co-
workers have demonstrated the possibility to graft carbohydrates with side chain 
of modified polymethylacrylates (PMMA), starting from side chain-modified 
PMMA, which present multiple acetylenic moieties that can ‘click’ a number of 
carbohydrates (e.g., 1-azidosugars, 6-azidosugars).19 
Surface modified nanoparticles with biomolecules by click chemistry could be 
applied for the targeted delivery or imaging. For instance, polycationic,20 
hydrophilic21 and amphipilic22 194 -cyclodextrin ‘click cluster’ had been 
developed via CuAAC reaction, obtaining an increasing in the serum stability of 
polymer repeat unit could without need grafting on large PEG chains to the 
polymer backbone. These copolymers formed polyplexes by complexing pDNA, 
and displayed a highly efficient pDNA delivery. Furthermore, fluorescent micelle 
with inorganic silica core with biocompatible polymer shell and a terminal unit 
susceptible to facile conjugations via click chemistry, were applied successfully for 
intracellular delivery and optical imaging which is demonstrated via in vitro 
experiments on lung cancer cells.23 
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However, clicked nanoparticles could be applied also in many other biological 
fields. In this respect, J. C. M. van Hest et al. developed clicked polymersome 
nanoreactors able to load enzyme and thus showed cellular uptake which can be 
applied for functional artificial organelles.24 
Certainly, due to facility with which sequential click reactions can be performed in 
macromolecules, these methodologies can be extended to the design of novel 
nanocarriers with any desired combination of ingredients…and nearly any 
conjugates you can imagine can be done by Click Chemistry. 
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1.5 Riboflavin in nanotechnology  
Riboflavin (Rfv), also known as vitamin B2, is a micronutrient with a key role in 
humans and animals health.  
Historically, it was originally recognized in 1879 as a growth factor and named 
vitamin B2 according to the British nomenclature system. Successively, it was first 
isolated from egg whites in 1934 and synthesized in 1935.1, 2 
As one of the family of B vitamins, riboflavin contributes to cellular growth, 
enzyme function, and energy production. It is a precursor of flavin 
mononucleotide (FMN) and flavin adenine dinucleotide (FAD) cofactors, and plays 
a key role in energy metabolism in eukaryotic cells.3 
From a chemical point of view, Rfv is composed from a D-ribitol chain conjugated 
to the N10 position of an isoalloxazine moiety, which is responsible for electronic 
and optoelectronic properties, such as UV absorption, fluorescence, redox 
properties and photosensitivity.3, 4  As a small molecule, Rfv has several functional 
groups that are amenable for covalent modifications,5 even though it is insoluble 
in water and most of organic solvents. 
N
N
N
NH
OR
O
O
OR
RO
OR
R H; COCH2CH2CH3
Riboflavin  
Figure 13. Chemical structure of riboflavin (Rfv) and its tetrabutyrate detivative. 
 
However, it is not synthesized in situ, and riboflavin intake is by food. In humans, 
after ingestion, three Rfv transporters (RFT) and carrier protein (RCP-Riboflavin 
Carrier Protein) mediate Rfv internalization.6, 7 Moreover, overexpression of RCP 
was found in tumor tissues, in particular in the cases of breast,8 prostate9 and 
hepatocellular carcinoma.10  Nevertheless, the interactions between Rfv and 
cancer cells is quite complex and the regulative mechanisms is not well clarified 
yet. 
Thanks to these interesting peculiarities, a number of Rfv applications in 
nanotechnology have been recently investigated. In this respect, Rfv or its 
derivatives were utilized to decorate several nanosystems. 
On this purpose, B.-C. Ye and collaborators exploit the feasibility of the synthesis 
of novel gold nanoclusters (AuNCs) using riboflavin as a stabilizer, due the 
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stronger complexing property absorbing on metal surfaces (i.e. gold, silver etc.) 
through the C=O and –NH group.11 Even more, in the close 2016, F. Kiessling and 
co-workers evaluated the nucleotides AMP, ADP and ATP as spacers to stabilize 
FMN-targeted iron oxide nanoparticles.12 Moreover, Thomas et al. conjugated Rfv 
to the fifth generation (G5) polyamidoamine (PAMAM) dendrimer via N3 nitrogen 
of the isoalloxazine ring (N(3)-conjugates) or primary alcohol of ribitol chain 
(N(10)-conjugates).5 
In addition, our group have already developed a new nanohydrogel platform 
based on polysaccharides (Hyaluronan and Pullulan) modified with the 
hydrophobic Rfv tetrabutyrate, capable to induce self-assembling properties to 
the polysaccharide chains once chemically linked to such polymers.13 
Furthermore, due to its fluorescence properties, the amount of Rfv derivatives in 
the nanomedicine could be easily quantified. 
 
To date, the nano-conjugated Riboflavin systems are in the beginning of their 
investigation from researcher. However, use of Rfv in nanomedicine field could 
indeed represent a promising alternative, due to Rfv biocompatibility, low cost, 
versatile chemistry and specific transporter systems overexpressed in 
metabolically active cells. 
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1.6 Aim and outline of the thesis  
As stated above, the development of Nano Drug Delivery Systems (NDDS) is a 
promising approach for developing intelligent therapeutic systems, which will 
bring significant advances in the diagnosis and treatment of disease, with the 
challenges to maximize therapeutic activity and to minimize undesirable side 
effects. The aim of this thesis was focused on the design of two kind of self-
assembled nanocarrier for the delivery of hydrophobic drugs: Hyaluronan based 
nanohydrogel and pNIPAAm based micelles that both show hydrophobic internal 
domains and a surrounding hydrophilic shell. 
   To achieve such self-assembled nanostructures, amphiphilic polymers were 
synthesized and extensively characterized. Hyaluronan (HA) and the 
thermosensitive di-block copolymer of methoxy poly(ethylene glycol)-b-(N-
isopropylacrylamide)-co-(2-azidoethyl) methacrylate (mPEG-b-p(NIPAAm)-co-
AzEMA) constituted the starting polymers on which  riboflavin 2',3',4',5'- 
tetrabutyrate (Rfv), due to its interesting chemical-physical proprieties and due to 
its particularly biocompatibility, was conjugated as hydrophobic moiety via azide-
alkyne click chemistry reaction.   
   The HA-Prop derivatives were synthesized in order to provide the polymer of 
alkyne groups and make it versatile for “click” reaction. In this way, the azido-
hexyl derivative of riboflavin tetrabutyrate was synthesized and covalently 
coupled to the propargyl derivative of hyaluronic acid by Copper(I)-catalyzed 
Azide-Alkyne Cycloaddition (CuAAC), due to the high efficacy and selectivity of this 
kind of reaction. 
Sterile self-assembled NHs were obtained in one-step by thermal treatment in 
autoclave of the aqueous dispersion of the HA-c-Rfv polymers. Size and 
polydispersity of the obtained NHs resulted be influenced from the Mw and from 
the degrees of derivatization of the starting Hyaluronan.  
   Micellar nano-assemblies composed of thermosensitive amphiphilic block 
polymers were formed by heating the aqueous solutions of the resulting 
poly(NIPAAm) block copolymer, in order to obtain temporal control of the release 
of the encapsulated drugs. For this purpose, mPEG-b-p(NIPAAm)-co-AzEMA block 
copolymer was synthesized by free radical polymerization and subsequently, a 
propargyl derivative of riboflavin (Rfv-Prop) was synthesized and covalently 
coupled to the azide modified diblock copolymers by Copper(I)-catalyzed Azide-
Alkyne Cycloaddition (CuAAC).  
   The nanosystems thus formed were intended to be used for the delivery of 
hydrophobic drugs, thus taking advantages of the lipophilic core represented by 
riboflavin. Moreover, the potential π-π stacking interactions between the 
aromatic rings of the riboflavin in the core of such nanocarriers, may bring more 
stable nanostructures able to provide increased loading capacity.  
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In Chapter 2  
the synthesis and characterization of amphiphilic HA-c-Rfv derivatives are 
reported. The strategy used to obtain self-assembled NHs, based on the method 
to form and sterilize, in one step, using an autoclave, is described. The HA-c-Rfv 
NHs were loaded with hydrophobic drugs (i.e. piroxicam, dexamethasone and 
paclitaxel), and characterized in terms of loading efficiency, stability and physico-
chemical properties. 
 
 
In Chapter 3 
the synthesis and characterization of a novel thermosensitive polymer, mPEG-b-
p(NIPAAm)-co-AzEMA-Rfv, is described which forms polymeric micelles. Stability 
of micelles and drug loading capacity for paclitaxel (PTX) were  studied. Moreover, 
we hypothesized that by exploiting the hydrophobic interactions and the potential 
π-π stacking interactions that might exist between the aromatic rings of riboflavin 
and the drugs molecule (containing aromatic rings as well) would affect loading  
and release of this drug from the micelles. 
 
 
In Chapter 4 
finally are summarized the results of the aforementioned chapters and the 
perspectives for the optimization of this promising Nano Drug Delivery Systems.  
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ABSTRACT: Highly hydrophilic and biocompatible nanocarriers based on 
polysaccharide hydrogels (nanohydrogels, NHs) were shown to be promising 
systems for drug delivery applications. Inspired by these emerging and promising 
drug carriers for therapeutic applications, in this work we aimed to develop self-
assembled hydrogel nanoparticles based on amphiphilic derivative of hyaluronic 
acid (HA). For this purpose, new HA-Riboflavin (HA-c-Rfv) derivatives were 
synthetized by “click” Copper(I)-catalyzed Azide-Alkyne Cycloaddition (CuAAC) 
reaction, requiring a previous HA derivatization with alkyne moieties and 
Riboflavin modification with azide groups. The resulting amphiphilic product was 
able to form nanohydrogels in aqueous environments by suitable treatments, in 
particular by an innovative method by using an autoclave cycle.  
   Various HA molecular weights (Mw) and derivatization degrees of the starting 
polymers have been used in order to assess the effect of different parameters on 
the NHs formation. The derivative HA220-c-Rfv (Mw 220kDa, 40% of propargylic 
portions and 40% of Rfv moieties), was chosen as the most interesting NHs 
forming system; NHs were 150-200 nm in size and showed a ζ-potential in the 
range -40 / -50 mV, depending on the experimental conditions adopted. NHs 
resulted to be stable in water and at physiological pH. Moreover, by the addition 
of a suitable cryoprotectant, the NHs suspension can be freeze-dried and 
recovered by re-suspension in water. 
   The developed system is intended to be used for the delivery of hydrophobic 
drugs, such us dexamethasone, piroxicam and paclitaxel, used as model drugs. 
Drug encapsulations were performed by hydrating drugs film with polymers 
aqueous suspensions, followed by an autoclave treatment, resulting in a high 
encapsulation efficiency (EE%).  
   Moreover, the HA-propargyl backbone with 60% of propargylic portions and 
partially linked to Rfv, was capable to react with other molecules bearing an azide 
group, opening the route to a wide spectrum of functionalization opportunities: in 
this direction, PEG-N3 have been tested as model molecule for the NHs.  
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Introduction  
   Hydrogels nanoparticles (also known as polymeric nanohydrogels (NHs)) have 
captured attention as one of the most promising nanostructured drug delivery 
systems, in terms of loading capacity, stability, release and targeting profile of 
several therapeutic and/or diagnostic agents.1 
Such a nanoparticulate result very interesting and notable because of their unique 
physico-chemical properties that combine the characteristics of hydrogel systems 
(as the soft consistency, the high water content and the low interfacial tension 
with water and biological fluids) with a very small size (in the nano-scale). These 
unusual peculiarities make NHs more similar to living tissues than many other 
classes of synthetic nanosystems.2 
   Nanohydrogels prepared from natural polymers (including polysaccharides) 
offer several advantages and are non-toxic, generally biocompatible, and 
biodegradable (a must to avoid organ accumulation and other undesirable side 
effects). 3,4 On this purpose, a wide range of polysaccharides were already 
investigated such as pullulan,5 chitosan,6 alginate,7 and hyaluronic acid.8-10  They 
exhibit quite variable structures and properties, different reactive groups, a wide 
range of molecular weights and variable chemical composition. They can be easily 
derivatized with hydrophobic moieties to form amphiphilic polymers that 
spontaneously self-assemble in aqueous media, thus forming NHs.  
   Molecular self-assembly is defined as the autonomous organization of 
components into structurally well-defined aggregates, characterized by specific 
association of molecules through non-covalent interactions, including 
electrostatic and/or hydrophobic associations, in order to minimize the interfacial 
free energy.11  
Inspired by these emerging and promising drug carriers for therapeutic 
applications, in this work we aimed to develop hydrogel nanoparticles formed by 
self-assembly based on an amphiphilic derivative of hyaluronic acid.  
   Among polysaccharides, hyaluronic acid (HA) seems to be one of the most 
interesting materials for the development of biocompatible drug carriers; it is one 
of the major components of the extracellular matrix (ECM) and is present at high 
concentrations in all connective tissues (cartilage, in the vitreous humor and in 
synovial fluids). Moreover, due to its capacity to interact with some cell receptors, 
HA plays an important role in cell proliferation, migration and differentiation.12 
Indeed, HA provides an active targeting to CD44 receptor, a transmembrane 
glycoprotein over-expressed on the surface of some cancer cells (e.g. solid 
tumors). In this regard, HA is a good candidate for systemic drug delivery 
applications. 8, 10, 13, 14 
   From a chemical point of view, HA is a linear non-sulphated glycosaminoglycan 
composed of β-1, 4-linked disaccharide units of β-1, 3-linked D-glucuronic acid 
and N-acetyl-glucosamine. In physiological conditions, HA is in the form of a 
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sodium salt, therefore negatively charged and referred to as sodium hyaluronate. 
In these conditions, it is highly hydrophilic. HA can be modified in order to obtain 
materials with new physico-chemical and biological characteristics. The chemical 
modification of HA can be performed mainly on the two available functional sites: 
the carboxylic acid group and the hydroxyl groups. 
   Riboflavin (Rfv) (Vitamin B2) is an interesting molecule with important 
properties15 such as biological activity as coenzyme for the flavoenzymes Flavin 
adenine dinucleotide (FAD) and Flavin mononucleotide (FMN).16 Chemically, 
Riboflavin consists of an isoalloxazine ring responsible for the UV absorption, 
fluorescence, redox properties and photosensitivity.15 It is widely distributed in 
nature and particularly biocompatible.  
   For this purpose, new HA derivatives were synthesized in order to provide the 
polymer of alkyne groups and make it versatile for “click” reaction. In this way, the 
azido-hexyl derivative of riboflavin tetrabutyrate was synthesized and covalently 
coupled to the propargyl derivative of hyaluronic acid by Copper(I)-catalyzed 
Azide-Alkyne Cycloaddition (CuAAC), due to the high efficacy and selectivity of this 
kind of reaction.17-20     
   The amphiphilic nature of the synthetized polymer hyaluronic acid-riboflavin 
(HA-c-Rfv) allowed the formation of NHs by macromolecular self-association. HA 
nanogels are composed of HA chains that are associated into three-dimensional 
soft nanomatrices. With their high water content, these HA nanogels are similar 
to macroscopic bulk hydrogel materials and thus belonging to soft drug delivery 
systems.  
Different molecular weights (Mw) and different degrees of derivatization of the 
starting polymer have been investigated in order to study the effect of these two 
parameters on the NHs formation. Usually, self-assembled NHs are formed by 
bath-sonication in aqueous media,8 or reverse nanoprecipitation process.34  
In this case, NHs were formed by an innovative method based on the use of an 
autoclave sterilization cycle (121°C, 20 min 1.1 bar).30 This method can thus lead, 
in a single step, the formation of sterile NHs. Moreover, during the same 
procedure, these nanoparticles can be loaded with hydrophilic and lipophilic 
drugs.21 The obtained nanohydrogels were characterized in terms of size (DLS-
analysis),  potential, and stability in different conditions. 
   The developed system is intended to be used for the delivery of hydrophobic 
drugs. The hydrophobic nature of such drugs is a serious hurdle in their efficient 
formulation and restricts their use in aqueous based solvents. With a view to 
overcome such limitations, several hydrophobic drugs-loaded nano-formulations 
were investigated and well described in literature.23-28 In the present work, we 
described the synthesis of HA-c-Rfv derivative, the preparation of NHs and their 
loading hydrophobic drugs, having at least, one aromatic ring (such as piroxicam, 
dexamethasone and paclitaxel). We assumed that drug are accomodated in the 
lipophilic core (associated to riboflavin moieties), exploiting the hydrophobic 
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interactions and the π-π stacking interactions that might exist between the 
aromatic rings of riboflavin and the drugs molecules.22 
   Finally, surface-modification of delivery vehicles with polyethylene glycol (PEG) is 
usually adopted to improve the stability and in vivo performance of various drug 
and gene vectors. In addition, PEGylation has recently been shown to dramatically 
improve particle transport through biological barriers.36-42  
For this purpose, on the polymers HA-c-Rfv with a excess of propargylic moieties 
still available for further conjugation, PEG-N3 chains were coupled to NHs by 
azide/alkyne click reaction, in order to additionally improve such innovative and 
versatile nanocarriers.  
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2.2 Materials and Methods 
 
2.2.1 Materials 
Hyaluronan sodium salt (HANa) was provided by Contipro, Dolní Dobrouč, Czech 
Republic and it was modified  in hyaluronan tetrabutylammonium salt (HATBA) 
form by using a Dowex cation exchange resin. Methoxypolyethylene glycol azide 
(PEG-N3, number-average molar mass Mn = 2000 g mol-1), sodium azide (NaN3), 
1,6-dibromohexane, sodium chloride (NaCl), propargyl bromide solution 80 wt. % 
in toluene (PropBr), anhydrous sodium sulfate (Na2SO4), sodium hydroxide 
(NaOH), ethylenediaminetetraacetic acid disodium salt dihydrate (EDTA), 
copper(II) sulfate (CuSO4), L-ascorbic acid, potassium carbonate (K2CO3), 
potassium bromide (KBr), glycerol, dextrose, piroxicam (PIR) and dexamethasone 
(DEX), acetonitrile (ACN), dichloromethane (DCM), acetone, ethyl acetate, n-
hexane, N,N-dimethylformamide (DMF), trifluoroacetic acid (TFA), ethanol (EtOH), 
and dimethyl sulfoxide (DMSO) were purchased from Sigma-Aldrich. Riboflavin 
tetrabutyrate was purchased from TCI Europe. Paclitaxel (PTX) was purchased 
from LC Laboratories (MA, U.S.A.). Simulated Intestinal Fluid without Enzyme (SIF) 
pH 7.4 buffer was prepared as following: NaH2PO4 H2O 0.5243 g and Na2HPO4 
2.2997 g in 200 ml of MilliQ water.  
 
2.2.2 Synthesis of 2’3’4’5’- tetrabutyril-3-(6-azidohexyl) riboflavin (RfvN3) 
RfvN3 derivative was synthesized in a two-steps synthesis. The first step provided 
the synthesis of 2’3’4’5’- tetrabutyril-3-(6-bromohexyl) riboflavin (RfvBr) 
derivative as described by C. Di Meo et al.21 Briefly, 500 mg of 2’3’4’5’-
tetrabutyrilriboflavin (0.761 mmol) were solubilized in 4.5 ml of dry DMF under N2 
atmosphere. Then 158 mg of K2CO3 (1.14 mmol) was added and the reaction was 
stirred for 45 min. Afterwards, 0.470 ml of a solution of 1,6-dibromohexane (0.74 
g, 3.0 mmol) was added dropwise in 2.5 ml of DMF and the mixture was stirred for 
5 h. The reaction was monitored by TLC (SiO2, dichloromethane/ethyl acetate 4/1) 
and ESI-MS. The crude product was then purified first by liquid-liquid organic 
extraction, the product was collected in the organic phase, dried over Na2SO4 and 
the solvent was evaporated. The crude product was purified by open column 
chromatography (SiO2 40-63 m), and collected as yellow/orange fraction. (Yield ~ 
50%) (Eluents: first elution n-hexane, then DCM/ethyl acetate 4/1).  
1H NMR (CDCl3) δ (ppm) 8.04 (s, 1H), 7.57 (s, 1H), 5.70 (br s,1H), 5.47 (m, 2H), 4.91 
(br s, 2H), 4.48 (d, 1H), 4.23 (dd, 1H), 4.07 (t, 2H), 3.40 (t, 2H), 2.57 (s, 3H), 2.46 (s, 
3H), 2.30 (t, 2H), 2.07 (m, 1H), 1.86 (m, 3H), 1.74–1.60 (m, 10H), 1.66 (dd, 2H), 
1.54–1.21 (m, 6H), 1.0 (q, 6H), 0.94 (t, 3H), 0.63 (t, 3H). 
FT-IR (KBr) cm−1 2964, 2936, 2874, 1745, 1663, 1550, 1158. 
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ESI–MS (+) m/z 821, 843 [M + Na]+. 
The azido-derivative of the riboflavin was synthetized by nucleophilic substitution 
of the terminal -Br of the RfvBr with an azido group. Briefly, 500 mg of 2’3’4’5’- 
tetrabutyril-3-(6-bromohexyl) riboflavin (0.61 mmol) and 198 mg of NaN3 (3.05 
mmol) were dissolved in DMF and left reacting under slow stirring for 6 hours. The 
reaction was monitored by ESI-MS. Then, DCM was added to the crude product 
and it was washed with brine for 5 times. The organic phases were dried over 
Na2SO4 and the pure product was collected as orange/red solid after solvent 
evaporation (Yield ~ 98%). 
1H NMR (CDCl3) δ (ppm) 8.04 (s, 1H), 7.57 (s, 1H), 5.70 (br s,1H), 5.47 (m, 2H), 4.91 
(br s, 2H), 4.48 (d, 1H), 4.23 (dd, 1H), 4.07 (t, 2H), 3.28 (t, 2H), 2.57(s, 3H), 2.46 (s, 
3H), 2.30 (t, 2H), 2.07 (m, 1H), 1.74–1.60 (m, 10H), 1.66 (dd, 2H), 1.0 (q, 6H), 0.94 
(t, 3H), 0.63 (t, 3H). 
FT-IR (KBr) cm−1 2964, 2936, 2874, 2100, 1745, 1663, 1550, 1158. 
ESI–MS (+) m/z 782, 804 [M + Na]+. 
 
2.2.3 Synthesis of propargyl derivatives of Hyaluronan (HA-Prop) 
HATBA was dissolved in DMSO until complete solubilization. Then, PropBr solution 
was added dropwise at the mixture in order to obtain the desired stoichiometric 
derivatization degree (mol Rfv/mol HA repeating units). The reaction was carried 
out for 40 h at room temperature under magnetic stirring, and purified by 
exhaustive dialysis against distilled water (Visking tubing, cut-off: 12-14 kDa); the 
final product HA-Prop was finally collected as white fluffy solid after freeze-drying 
(Yield ~ 90%). 
1H NMR (D2O) δ (ppm) 4.78 (-CH2C≡CH, s), 3.06 (CH3CH2CH2CH2N+, t), 2.92 (-
CH2C≡CH, s), 1.87 (CH3CONH-HA, s), 1.51 (CH3CH2CH2CH2N+, m), 1.23 
(CH3CH2CH2CH2N+, m), 0.81 (CH3CH2CH2CH2N+, t). 
FT-IR ATR 3305, 2876, 1649, 1752, 1076 
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2.2.4 Hydrolysis reaction of the HA-prop derivative 
HA-Prop derivative was dissolved in H2O and NaOH 0.25 M at 40°C. Aliquots were 
withdrawn at different timeslots (2, 4, 6 and 20 h) and purified by dialysis against 
water from the propargyl alcohol formed after the cleavage of the ester bond. 
Next, the purified HA-Na obtained was freeze-dried and analyzed by 1H NMR.  
1H NMR (D2O) δ (ppm) 3.06 (CH3CH2CH2CH2N+, t), 1.87 (CH3CONH-HA, s), 1.51 
(CH3CH2CH2CH2N+, m), 1.23 (CH3CH2CH2CH2N+, m), 0.81 (CH3CH2CH2CH2N+, t). 
 
2.2.5 Synthesis of HA-c-Rfv derivatives by click-chemistry  
The HA-c-Rfv products were synthetized using HA-Prop and RfvN3; the coupling 
was obtained by azido-alkyne “click chemistry” reaction. 
HA with different Mw (57, 115, 220 and 280 kDa) were used to obtain different 
derivatization degree (feed propargyl percentage of 40, 60, 80 and 100%; feed 
riboflavin percentage of 20, 40, 50, 64 and 100 %); coupling reaction were carried 
out thus obtaining a set of products HA-c-Rfv. 
In a typical reaction, the polymer HA-Prop was dissolved in a mixture of 
DMSO/H2O 85/15; then, depending on the desired degree of substitution, the 
suitable amount of RfvN3 previously dissolved in DMSO was added dropwise to 
the reaction mixture. CuSO4 and ascorbic acid at the final concentration of 0.65 
mg/ml were added to the mixture and the reaction was carried out at room 
temperature for 2 hours. 
The products were then exhaustively dialyzed against a 10 mM EDTA solution, 
then against distilled water. Next, products purification was optimized by 
centrifugation (4000 rpm, 30 min). The products were finally collected as yellow 
fluffy solids after freeze-drying (Yield ~ 84-89 %). 
 
2.2.6 HA derivatives characterization  
The synthetized polymers were characterized by 1H NMR (Agilent 400 MHz 
spectrometer), FT-IR ATR  (PerkinElmer Spectrum 100 Optica FT-IR spectrometer), 
GPC (Viscotek 305 TDA) and UV-Vis spectroscopy (PerkinElmer LAMBDA 25 UV/Vis 
system).  
1HNMR spectra were recorded using Agilent 400 MHz spectrometer (Agilent 
Technologies, Santa Clara, California, US) using D2O as solvent (solvent signal at 
4.79 ppm) in order to obtain information about the derivatization degree of HA-
Prop derivatives. The value of the signal of the methylene group of HA (–C=OCH3, 
1.87ppm) was normalized for 3 protons and used as reference signals. Based on 
this normalization, the signals of the propargylic protons (-CH2-C≡CH, 2.90 ppm; -
CH2-C≡CH, 4.76 ppm) were integrated and the area under the curve, divided for 
Chapter 2 
66 
 
the respective numbers of protons that took place at the resonance process, gave 
information about the substitution degree of HA. 
Molecular weight analysis and polydispersity index determination were conducted 
by GPC measurements. The Viscotek Triple Detector Array (TDA) incorporates RI, 
Light Scattering, Viscosity detectors. A universal calibration (running a single 
narrow standard of which all the parameters are known) was made in order 
calculate the detector constants and to correct for the inter-detector delay 
volumes, by using a Polyethylenglycol (PEO, 24 kDa) as narrow standard, and 
Dextran (73 kDa) as broad standard, for aqueous elutions; Pullulan (105 kDa) as 
narrow standard, and Dextran (73 kDa) as broad standard for DMSO elutions. 
Each synthesized polymer was filtered through a 0.2 µm syringe filter prior to 
analysis, and then injected at different concentrations (from 1 to 4 mg/ml) in 
order to obtain the proper dn/dc value, characteristic of each polymer. Eluents 
used were aqueous solution of NaNO3 0.1 M + NaN3 0,01 % w/V for the elution of 
HA-TBA, and HA-Prop derivatives and DMSO for the HA-c-Rfv derivatives. The flow 
rate was 0.6 ml/min by three seral columns (TSK gel 13m, 300x7.8, 100-1000 Å) 
at 35°C for the aqueous elutions; two seral columns (Phenogel 5m, 300x7, 500 
and 105 Å), at 60 °C for DMSO elutions.  The GPC chromatograms were 
riealobrated by software to calculate the molecular weight (Mw), polydispersity 
index (PDI), intrinsic viscosity (IV), hydrodynamic radius (Rh), α and K of the Mark-
Houwink equation. 
The expected mass average molar mass or Mw of the polymers were calculated by 
the following equation:  
 
𝑀𝑤 =  ∑(𝑀𝑊𝐻𝐴 𝑟𝑒𝑝𝑒𝑡𝑖𝑡𝑖𝑣𝑒 𝑢𝑛𝑖𝑡 + %𝑀𝑊 𝑃𝑟𝑜𝑝 + %𝑀𝑊 𝑅𝑓𝑣) ∗ 𝑁° 𝑟𝑒𝑝𝑒𝑡𝑖𝑡𝑣𝑒 𝑢𝑛𝑡𝑠   
 
FT-IR ATR spectra of the polymers were measured using a Spectrum 100 Optica 
FT-IR spectrometer (PerkinElmer, Waltham, Massachusetts, US) in ATR mode. A 
spectral resolution of 4 cm− 1 with 64 co-added scans was used for collection of 
reference spectra over a spectral range of 4000–600 cm− 1. 
UV-Vis spectra of the HA-c-Rfv derivatives were carried out using a LAMBDA 25 
UV/Vis system (PerkinElmer, Waltham, Massachusetts, US). Bandwidth fixed at 1 
nm, light source of deuterium and tungsten prealigned sources with automatic 
switch-over; wavelength range from 200 to 600 nm.  
The calibration curve was established with RfvN3 standards in a concentration 
range of 100-6.25 g/ml in DMSO. Unknown samples were dissolved in DMSO at 
starting concentration of 1 mg/ml and diluted 5, 10 and 20 folds. Acquisition of 
the absorbance intensities were performed at 346 and 450 nm.  
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2.2.7 NHs formation and characterization 
In a typical experiment, 3 mg of each derivative HA-c-Rfv were dispersed in 3 ml of 
distilled water (1 mg/ml) by overnight magnetic stirring at room temperature. The 
samples were then autoclaved for 20 min at 121 °C (Juno Liarre autoclave 230 
Vac, 50/60 Hz, 12A, 2000 W), leading to NHs formation.30 The recovered  NHs 
suspensions were then analyzed in terms of size and polidispersity index (PDI) by 
dynamic light scattering (DLS) using Submicron Particle Sizer Autodilute Model 
370 (Nicomp). The  ζ-potential was measured with a DLS Malvern NanoZetaSizer 
apparatus (Malvern Instruments, Worcestershire, United Kingdom), equipped 
with a 5 mW HeNe laser (k = 632.8 nm). Normalized intensity autocorrelation 
functions were detected at a 90 ° angle by a logarithmic digital correlator and 
analyzed by Contin algorithm. 
Stability studies of HA-c-Rfv NHs suspensions, prepared as above described, were 
carried out by monitoring  the size and PDI values of NHs in water at 4 °C for 72 
days, and at 37 °C in glycerol/Simulated Intestinal Fluids (SIF) (pH 7.4) media for 
48 hours.  
 
2.2.8 Hydrophobic model drugs loading in HA-c-Rfv NHs 
Piroxicam (water solubility 23 g/ml at 22 °C, logP 3.06), dexamethasone (water 
solubility 89 g/ml at 25 °C, logP 1.83) and paclitaxel (water solubility 5.56 g/ml, 
logP 3.54) were chosen as model drugs.35  
In a typical preparation, a drug thin film was formed in a vial by evaporating under 
vacuum 0.5 ml of a drug solution in acetone (2 mg/ml). Next, a polymeric aqueous 
suspension (1 mg/ml, 3 ml), was added in the vial and stirred for 1 h to hydrate 
the drug film. The system was then autoclaved in order to form, in one-step, drug-
loaded NHs.30 The non-encapsulated drug was removed by centrifugation (3000 g, 
10 min), the pellet was then dissolved in ACN or EtOH and analyzed by HPLC in 
order to evaluate the amount of un-loaded drug. The drug-loaded NHs dispersions 
were analyzed in term of size by DLS measurement while the amount of the 
different drugs loaded in the NHs were evaluated by isocratic HPLC 
chromatography, using a Eurospher II C18 (5 m, 4.6x250 mm) column. The 
eluents used at flow rate 1 ml/min were: a mixture of ACN/water (50/50) + TFA 
0.1% V/V for the elution of piroxicam, a mixture of ACN/water (50/50) for the 
elution of dexamethasone, and a mixture of ACN/water (60/40) + TFA 0.1% V/V 
for the elution of paclitaxel. The detection was performed by UV detector at 356 
nm for piroxicam, 239 nm for dexamethasone, and 227 nm for paclitaxel. Samples 
of drugs in EtOH in a concentration range from 2 to 250 g/ml were used as 
standards for the calibration.  
Encapsulation Efficiency (EE) and Drug Loading (DL) were calculated from the 
HPLC analysis data, based on these equations:  
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%𝐸𝐸 =  
 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 𝑜𝑓 𝑑𝑟𝑢𝑔 𝑙𝑜𝑎𝑑𝑒𝑑
𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 𝑜𝑓 𝑑𝑟𝑢𝑔 𝑎𝑑𝑑𝑒𝑑
 𝑥 100 
 
%𝐷𝐿 =  
𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 𝑜𝑓 𝑑𝑟𝑢𝑔 𝑙𝑜𝑎𝑑𝑒𝑑
𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 𝑜𝑓 𝑑𝑟𝑢𝑔 𝑙𝑜𝑎𝑑𝑒𝑑 + 𝑝𝑜𝑙𝑦𝑚𝑒𝑟 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛
 𝑥 100 
 
Stability studies of drug-loaded NHs suspensions, prepared as above described, 
were carried out by monitoring the size and PDI of NHs in water at 4 °C for at least 
50 days. 
 
2.2.9 Drug-loaded NHs freeze-drying 
Purified drug-loaded NHs suspensions were added of a dextrose solution (10% 
w/V) in order to obtain a final concentration of 1% w/V of cryoprotectant. The 
samples were frozen in liquid nitrogen and freeze-dried. The recovered drug-
loaded NHs powders were then suspended in water and their size and PDI were 
assessed by DLS analysis. 
 
 
2.2.10 PEG-N3 conjugation to HA-c-Rfv by click chemistry reaction and PEG-NHs 
formation  
PEG-HA220-c-Rfv 60-40 was synthetized starting from the derivative HA220-c-Rfv 60-
40; the coupling was carried out by using azido-alkyne click chemistry reaction. HA 
220 kDa of Mw, with 60% of propargyl derivatization degree and 40% of riboflavin 
percentage, was dissolved in a mixture of DMSO/H2O 85/15. Then, an excess of 
PEG-N3 previously dissolved in DMSO was added dropwise at the reaction. CuSO4 
and ascorbic acid at the final concentration of 0.65 mg/ml were added at the 
mixture and the reaction was carried out in dark, at room temperature for 4 
hours. The product was then exhaustively dialyzed against a 10 mM EDTA solution 
overnight, and next against distilled water. Finally, the product was collected as 
yellow fluffy solids after freeze-drying (Yield ~ 80 %).  
PEGhylated NHs based on PEG-HA220-c-Rfv derivative were formed as previously 
described in aqueous suspension (1 mg/ml and 2 mg/ml) and analyzed in terms of 
size, PDI and ζ-potential as described in 2.2.7.  
1H NMR (D2O) δ (ppm) 3.57 (CH3OCH2CH2, br, PEG), 1.88 (CH3CONH-HA, s). 
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2.3 Results and Discussion 
 
2.3.1 Synthesis of 2’3’4’5’- tetrabutyril-3-(6-azidohexyl) riboflavin (RfvN3) 
In the synthesis of RfvN3 derivative, the first step was the preparation of the 
2’3’4’5’- tetrabutyril-3-(6-bromohexyl) riboflavin (RfvBr) derivative, as described 
by C. Di Meo et al.21  Next, the conversion of the 6-bromohexyl to 6-azidohexyl-
riboflavin derivative was carried out by a nucleophilic substitution of the Br with 
an azido group, using a large excess of NaN3, as shown in the Scheme 1.  
N
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N
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RfvBr RfvN3
R: COCH2CH2CH3
 
 
RfvN3 was obtained in a high yield (~98%) and its structure was confirmed by 1H 
NMR analysis (Figure 1A). The overlapped spectra of the RfvBr and the RfvN3 
derivative clearly show the shift from 3.4 ppm (-CH2Br) to 3.2 ppm (-CH2N3) of the 
signal of the methylene group adjacent to the nucleophilic terminal substituent. 
RfvBr and RfvN3 were analyzed by FT-IR spectroscopy (Figure 1B). Comparing the 
two spectra, the strong asymmetric vibration (N≡N asymmetric stretching 
absorption) at 2100 cm-1 confirmed the chemical structure of the RfvN3 derivative.  
 
A)                                                                       B)  
 
Figure 1. (A) 1H NMR spectra in CDCl3 of RfvBr (in green) and RfvN3 (in red). The area of resonances 
of methylenes near to the  nucleophilic terminal substituent is evidenced. (B) FT-IR spectra of RfvBr 
(in green) and RfvN3 (in red).  The asymmetric vibration at 2100 cm-1 is evidenced in the azido-
derivative. 
Scheme 1. Conversion of 2’3’4’5’- tetrabutyril-3-(6-bromohexyl) riboflavin (RfvBr) to  
6-azidohexyl-riboflavin derivative (RfvN3). 
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2.3.2 Synthesis of propargyl derivatives of hyaluronan (HA-Prop) 
In this work, several coupling reactions were carried out starting from HA with 
different Mw (57, 115, 220 and 280 kDa), using various feed ratio, to reach the 
aimed substitution degrees (Table 2). 
Polysaccharides can be easily derivatized with small molecules in order to modify 
their physico-chemical properties, and in particular, their solubility and gelling 
ability.33 
In the present case, to obtain polymer chains able to couple with RfvN3 via click 
chemistry reaction, HA carboxylic groups were esterified with alkyne moieties 
(Scheme 2). 
O
O
HO
OH
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O- TBA+
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HO
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OH
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O
HO
OH
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HA -TBA HA-Prop
propargyl bromide
 
 
 
As well known, the nucleophilic substitution reaction needs a polar aprotic 
environment, avoiding water as solvent: for this reason, the tetrabutylammonium 
(TBA+) salt of HA, soluble in DMSO, 22 was used as starting polymer; PropBr was 
used as alkyne moiety donor for esterification on the polymer carboxylic groups. 
The amount of the PropBr was modulated proportionally to the desired 
stoichiometric derivatization degree (mol PropBr/mol HA repeating units). The 
reaction was carried out at room temperature for 40 h, purified by extensive 
dialysis and the white solid product was recovered by freeze-drying in high yield (~ 
90%). 
Exploiting the above described synthesis, various HA-Prop substrates, with degree 
of substitution (DS) of Prop ranging from 40 to 80%, were prepared, using various 
feed ratio of Prop to HA. 
HA-Prop products were analyzed by 1H NMR spectroscopy (Figure 2) in order to 
evaluate the degree of functionalization.  
Scheme 2. Synthesis of HA-Prop ester derivative from HA TBA salt and propargyl bromide. 
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Figure 2.1H NMR spectra of HA-Prop 53% (57 kDa) in D2O. 
The spectra showed the signal at 1.87 ppm relative to acetamido moiety of the N-
acetyl-D-glucosamine residue of HA, that was normalized for 3 protons and used 
as reference signals. The signal at 2.92 ppm is relative to the terminal proton of 
the alkyne portion (-CH2C≡CH), and the signal at 4.78 ppm is related to the 2 
protons of the propargyl substituent in α to the triple bond (-CH2C≡CH). The 
degree of modification was determined by comparison of the integration of these 
signals, divided for the respective numbers of protons that took place at the 
resonance process. In this shown spectra (Figure 2), the resulted derivatization 
degree, based on this calculation, was 53% mol/mol (mol of Prop/mol HA 
repeating unit). 
Moreover, to confirm that the HA substitution with PropBr resulted in 
esterification of carboxylic groups instead of the etherification of the hydroxyl 
groups, a typical hydrolysis of esters under mild basic conditions was carried out, 
since ether bond cleavage is only possible under strongly acidic or extremely basic 
conditions. Aliquots at different time slots (2, 4, 6 and 20 h) were analyzed by 1H 
NMR in order to monitor and verify the ongoing status of the hydrolysis reaction 
by the disappearance of the signals of the propargylic portion (2.92 ppm -
CH2C≡CH, 4.78 ppm -CH2C≡CH).  
As shown in Figure 3, already after only 2h of reaction, the two signals of the 
alkyne portion of the starting material HA-Prop 53% (57 kDa) were not present in 
the spectra, indicating a complete hydrolysis of the ester.  
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Figure 3. 1H NMR spectra in D2O, overlap of HA-Prop 53% (57 kDa) and aliquots at 2, 4, 6 and 20 h of 
the hydrolyzed HA-Prop. 
To further confirm the above described results, infrared spectra of the polymers 
HA-Prop were recorded (Figure 4). The spectra showed a strong stretching 
absorption at 1752 cm-1 due to the C=O of the ester groups. 
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Figure 4. FT-IR spectra in of HA220-Prop, overlap of different derivatization degrees: HA-Prop 40% (in 
orange), HA-Prop 60% (in green) and HA-Prop 80% (in blue). 
In Table 2, the characteristics of the prepared HA-prop samples are summarized.  
It is worth noticing that, when the feed ratio was higher than 60 % mol/mol, the 
resulting conjugates were insoluble in water because of their hydrophobicity due 
to the excess amount of conjugated Prop. Since the self-assembled hydrogel 
nanoparticles are formed based on an appropriate balance of hydrophilicity and 
hydrophobicity, the water-insoluble conjugates that might have high DS (>60) 
were no longer investigated in this study. 
HA-Prop 
2h 
4h 
6h 
20h 
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2.3.3 Synthesis of Hyaluronan-Riboflavin derivative by click reaction (HA-c-Rfv) 
The azidohexyl-riboflavin derivative was linked to HA modified chains, in order to 
remarkably change the water solubility of the polysaccharide. 
In this work, we proposed a coupling reaction of the RfvN3 derivative to the HA-
Prop polymers by azide-alkyne Huisgen 1,3-dipolar cycloaddition click-chemistry 
reaction using CuSO4/ascorbic acid as catalysts (Scheme 3).         
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In a typical reaction, the quantity of RfvN3 was modulated proportionally to the 
desired stoichiometric derivatization degree (mol Rfv/mol HA repeating units). 
CuSO4 and ascorbic acid were used as catalysts to yield Cu+ in situ. Further, a 
dialysis against EDTA solution was used to purify the polymer, complexing the Cu+ 
ions.  
With the aim to purify the product from the un-coupled riboflavin still remained 
after the following extensive dialysis against water, a cycle of mild centrifugation 
(4000 rpm, 30 min) on the aqueous suspension of the polymer was performed: in 
this way: due to its very low water solubility, the free riboflavin tetrabutyrate was 
separated as pellet. 
The yellow polymer obtained by freeze-drying was analyzed by FT-IR ATR in order 
to verify the disappearance of the azide absorption frequency at 2100 cm-1, thus 
monitoring the outcome of the reaction and of the purification process.  
FT-IR spectra reported in Figure 5A and 5B, clearly show the disappearance of the 
N≡N strong asymmetric stretching absorption at 2100 cm-1, relative to the excess 
of RfvN3 still remained after dialysis, together with the reduction (in terms of 
intensity) of the band at 1744 cm-1  relative to strong stretching C=O absorption of 
the ester bonds of the riboflavin tetrabutyrate. A very pure final polymer (HA-c-
Scheme 3. Click reaction between HA-Prop polymer and RfvN3. 
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Rfv) was thus obtained, concluding that the chosen purification process resulted 
successful. 
      A)                                                                     B)                              
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Figure 5. FTIR-ATR whole (A) and zoomed-in (B) spectra of HA-c-Rfv before (blue) and after (orange) 
purification by centrifugation. 
 
In order to quantify the amount of RfvN3 coupled to the polymers, several 
analyses were performed. 1H NMR in solution and HR-MAS NMR on the swollen 
solid product did not allow to obtain spectra useful for the identification of the 
aromatic signals of riboflavin in the down field region, probably because of the 
rigidity of the molecule and/or the strong hydrophobic interactions. 
From UV-Vis spectroscopy analysis carried out as described in 2.2.6 it was possible 
obtain a right quantification of the riboflavin bonded to the polymers. In 
particular, the analysis was performed with dual detection (at 346 and 450 nm, 
corresponding to the characteristic wavelengths of Rfv absorptions), and the ratio 
between the mol of RfvN3 (related to the absorbance values obtained) and the 
mol of the relative HA-Prop derivative on which Rfv was coupled, was considered 
the derivatization degree.  
In table 2 the characteristics of the prepared HA-c-Rfv derivatives are 
summarized. 
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2.3.4 Molecular weight characterization of HA derivatives  
GPC analysis was carried out in order to collect information about the fate of the 
molecular weight and molecular weight distribution during the synthetic steps. In 
particular, in this work, GPC Viscotek 305 TDA analysis was performed. When GPC 
is coupled with light scattering, viscometer and concentration detectors (known 
as triple detection), it can measure absolute molecular weight (Mw), 
hydrodynamic radius (Rh) and intrinsic viscosity (IV), and generate information on 
macromolecular structure, conformation, aggregation and branching. 
From the elution of HA220-TBA, HA220-Prop 40 and 60% in ionic strength buffered 
aqueous eluent, and of HA220-c-Rfv 40/40 and HA220-c-Rfv 60/40 in DMSO, 
information about the Mw of the synthesized polymers were obtained (Table 1). 
Table 1. Summary of the GPC data of the analyzed HA derivatives in terms of molecular weight (Mw), 
refractive index (dn/dc), polydispersity index (PDI), intrinsic viscosity (IV), hydrodynamic radius (Rh), 
α and K of the Mark-Houwink equation. 
 
Mw expected 
(kDa) 
Mw by GPC 
(kDa) 
dn/dc PDI 
IV 
 (dl/g) 
Rh  
(nm) 
α logK 
HA-TBA a, b 340 347 0.1024 1.6 3.81 26.4 0.838 -4.042 
HA-Prop 40% b 296 270 0.1280 4.1 3.35 22.7 0.676 -3.105 
HA-Prop 60% b 293 315 0.1280 4.1 3.15 22.9 0.608 -2.781 
HA-c-Rfv 40/40 c 395 209 0.0389 1.3 0.54 11.8 0.701 -3.981 
HA-c-Rfv 60/40 c 397 523 0.0389 1.5 0.55 15.6 0.574 -3.499 
 
a. HA of 220 kDa, relative to the HANa+ salt 
b. Elution performed in aqueous solution of NaNO3 0.1 M + NaN3 0,01 % w/V 
c. Elution performed in DMSO 
The first synthetic step provided the derivatization of the starting HA-TBA with a 
propargylic portion by an esterification of HA carboxylic groups. Looking at the Mw 
of the HA-Prop 40 and 60% obtained (270 and 315 kDa respectively), that resulted 
very close by the Mw expected (296 and 293 kDa respectively, calculated as 
described in 2.6), we might conclude that this synthetic step did not affect the 
structure and the molecular weight distribution of the starting polysaccharide.  
The second synthetic step was the “click” coupling (Cu+-catalyzed) of the 
azidohexyl-derivative of riboflavin on the propargylic-HA derivatives. From the 
elution of the resulting HA-c-Rfv in DMSO, no clear results in terms of Mw of the 
analyzed polymers were obtained (i.e. 209 kDa for the HA-c-Rfv 40/40 derivative, 
and 523 kDa for the HA-c-Rfv 60/40 derivative). These results let us conclude that 
DMSO may be not a good solvent for such derivatives, and further investigation is 
needed.  
This hypothesis can be supported by the IV values obtained, that resulted very low 
for the Rfv-derivatized polymers (0.54 and 0.55 for the HA-c-Rfv 40/40 and HA-c-
Rfv 60/40 respectively), suggesting a very closed disposition of the polymer chains 
Chapter 2 
76 
 
in DMSO. It has to be noticed that after the “click” coupling with RfvN3, a 
purification step with EDTA is necessary to purify from the Cu+ ions. The EDTA 
used in this work was the disodium salt dehydrate form, meaning that after the 
dialysis against EDTA solution, the less not derivatized HA-carboxylic groups were 
converted in Na+ salts, resulting in an HA form less soluble in dipolar aprotic 
solvents such as DMSO. 
The α values of the Mark-Houwink equation, reported in Table 2, decreased by 
derivatization of HA with Prop, suggesting that polymers become more flexible. 
This phenomenon can be explained by the fact that the derivatization of HA-
carboxylic groups reduced the charge density along the polymer chains, thus 
improving the flexibility of the polymer chains. 
 
2.3.5 Empty NHs preparation  
NHs can be easily obtained from HA-c-Rfv derivatives. It has been demonstrated 
that HA derivatized with hydrophobic moieties, in aqueous media is able to 
spontaneously self-assemble in NHs,21,22,29 with the aim of minimizing the 
interfacial free energy of the whole system. A new method to obtain NHs was 
tested, i.e. the autoclaving process, already used for the preparation of HA-
cholesterol and gellan-cholesterol24 sterile NHs suspensions. In this case, HA-c-Rfv 
suspended in water can be autoclaved to generate spontaneously NHs by self-
assembling of the polymer chains. The high temperature seems to be able to 
promote the interactions between hydrophobic moieties linked to the polymer 
chains (inter- and intramolecular interactions as well), thus forming sterile 
nanoparticulate suspensions. NHs were prepared by treating the water 
suspension of the all the synthetized polymers HA-c-Rfv (1 mg/ml) for 20 min at 
121°C, 1.1 bar, and characterized in terms of size by DLS analysis (Table 2). 
All the synthetized polymers were characterized in terms of degree of substitution 
(DS) obtained with the Prop by 1H NMR analysis, RfvN3 portions by UV-Vis 
spectroscopy, and in terms of the ability to form self-assembled NHs by DLS 
measurements.  
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In table 2, the obtained results are summarized: 
Table 2. Summary of the HA-c-Rfv polymers synthesized in terms of HA Mw, feed and experimental 
coupling of Prop (mol Prop/mol HA repeating units) and Rfv (mol Rfv/mol HA repeating units), and 
the relative dimensions of NHs obtained from these polymers.  
HA-TBA 
(Mw) 
%Prop %Rfv NHs Zave (nm) PDI 
Feed by NMR Feed by UV-Vis by DLS  
57 kDa 64 53 excess - no NHs - 
 64 55 63 - no NHs - 
 64 55 54 - no NHs - 
115 kDa 100 93 20 - no NHs - 
 80 60 50 - no NHs - 
220 kDa 40 39 40 35 162 ± 10 0.20 ± 0.05 
 60 56 40 39 232 ± 5 0.20 ± 0.03 
 80 61 - - - - 
280 kDa 40 40 25 - 250 ± 30 0.40 ± 0.03 
 40 40 40 - 160 ± 20 0.50 ± 0.02 
 40 40 50 - 320 ± 20 0.50 ± 0.05 
 60 54 25 - 230 ± 30 0.30 ± 0.13 
 60 54 40 - 280 ± 20 0.50 ± 0.22 
 80 - - - - - 
 
The data summarized in Table 2 suggest that the HA derivatization with 
propargylic portion was always a good strategy to easily modify the polymer 
chains and obtain a derivative in high yield and with a good derivatization degree 
(related to the feed), ranging in the error of 10%. The coupling with RfvN3 by click 
chemistry, as expected, resulted in quantitative derivatization, due to the high 
efficacy and selectivity of this kind of reaction.17-20 
Moreover, we can observe that both HA MW and the degree of functionalization 
with Prop and Rfv affected NHs formation and size. In particular, the HA-c-Rfv 
derivatives obtained from HATBA with Mw of 57 and 115 kDa (HA57-c-Rfv and 
HA115-c-Rfv, respectively), did not form NHs: in general, the physical self-assembly 
of amphiphilic polymers depends on the hydrophobicity/hydrophilicity balance of 
the portions of the polymers, as well as their Mw and chemical characteristics of 
the hydrophobic portions. Based on these considerations, it can be concluded that 
these polymers with relatively low Mw, even after derivatization, had a residual 
high hydrophilic character portion not balanced by the hydrophobic contribution 
of Rfv, resulting in water-soluble polymers. On the other hand, the HA220-c-Rfv and 
HA280-c-Rfv derivatives (obtained from HATBA with Mw of 220 kDa and 280, 
respectively), were able to form NHs with good dimensions and PDI, except for 
those with a Prop DS of 80% that resulted already water-insoluble; however, the 
Chapter 2 
78 
 
0
0,2
0,4
0,6
0,8
0
50
100
150
200
250
300
0 6 12 18 24 30 36 42 48
P
D
I
Si
ze
 (
n
m
)
Time (hours)
Size (nm) PDI
0
0,2
0,4
0,6
0,8
0
50
100
150
200
250
300
0 7 14 21 28 35 42 49 56 63 70
P
D
I
Si
ze
 (
n
m
)
Time (days)
Size(nm) PDI
NHs obtained with the HA280-c-Rfv derivatives presented higher PDI than those 
formed with HA220-c-Rfv.  
For this reason, the HA220-c-Rfv derivatives were chosen for further investigations 
as NHs constituents for drug delivery applications.  
 
2.3.6 Stability studies and drug-loaded NHs preparation  
Empty NHs obtained from the selected HA220-c-Rfv 40/40 derivative showed a size 
of 162 ± 10 nm, a PDI of 0.20 ± 0.05 and a ζ-potential of about −50 mV.  
The stability of the HA220-c-Rfv 40/40 suspensions was investigated in water at 4°C 
and NHs were stable for more than two months, whereas at 37°C in 
glycerol/Simulated Intestinal Fluids (SIF) (pH 7.4) media, NHs resulted stable for 
48 h, at least (Figure 6). 
 
A)                                                                  B) 
  
 
 
 
  
 
Figure 6. Average dimensions of empty HA220-c-Rfv 40/40 NHs as a function of time at 1 mg/ml (A) in 
water at 4°C, (B) in glycerol/Simulated Intestinal Fluids (SIF) (pH 7.4) media at 37°C. Data points are 
average values. Error bars indicate standard deviations (n=3). 
It is important to notice that HA220-c-Rfv 40/40 NHs were stable in physiological 
conditions while in the case of NHs previously prepared with HA-cholesterol 
derivatives aggregation occurred in few hours.8 This property represents a 
significant advantage of the new polysaccharide-Rfv NHs for their potential use in 
the field of pharmaceutics and biomedicine. 
In order to test the drug carrier properties of the new NHs developed, HA220-c-Rfv 
40/40 NHs were loaded with different hydrophobic model drugs. Piroxicam, a 
non-steroidal anti-inflammatory drug (NSAID), dexamethasone, a type of steroid 
medication, and paclitaxel, an anticancer drug, were chosen as model drugs. The 
autoclaving process was exploited allowing the formation of NHs and the loading 
of these drugs in one step.32 This methodology allow the loading of hydrophobic 
drugs by the solvent-casting technique.  
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Dispersions of drugs-loaded NHs of HA220-c-Rfv 40/40 prepared at polymer/drug 
ratio of 3/1 (feed loading concentration of 25%), resulted to be opalescent and 
homogeneous.  
After purification, the NHs dispersions were analyzed in term of size by DLS 
measurement (Table 3). 
Table 3. Z-average size of empty and drug-loaded NHs. 
 
*(pol. Conc. 1mg/ml in H20) 
After removing the non-encapsulated drugs by mild centrifugation, the 
Encapsulation Efficiency (EE%) and Drug Loading (DL%) were calculated for all the 
drugs tested, indicating that HA220-c-Rfv 40/40 NHs are suitable systems for 
loading and carrying hydrophobic drugs.  In detail, as shown in Figure 7, for the 
HA220-c-Rfv 40/40 based NHs, EE% values of 82 ± 8, 84 ± 6 and 42 ± 4 % were 
obtained for the PIR, DEX and PTX-loaded NHs respectively. The collected data in 
terms of DL% values resulted be 21 ± 1, 22 ± 2 and 12 ± 1   %, all relative to the 
25% PIR, DEX and PTX respectively feed loading, confirming that these NHs act as 
solubility enhancers, increasing the solubility of poorly water soluble drugs, when 
loaded in such aggregated structures.  
 
 
As reported in literature,35 the water solubility values of the tested drugs are 23, 
89 and 5.56 g/ml for PIR, DEX and PTX respectively. Based on our analysis, the 
reached concentration of these drugs loaded into our NHs resulted be 274, 280 
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Figure 7. Encapsulation Efficiency (EE%) and Drug Loading (DL%) of Piroxicam, Dexamethasone 
 and Paclitaxel -loaded NHs. 
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and 141 g/ml, meaning an increase of the apparent water solubility of 12, 3 and 
25-fold respectively. 
Additionally, as shown in Figure 8, the storage at 4°C of these drug-loaded 
formulations resulted in stable formulation for at least two months. 
 
Figure 8.  Average dimensions of PIR-loaded (in green), DEX-loaded (in orange) and PTX-loaded NHs 
(in blue) as function of the time, in water at 4 °C. Samples were analyzed in triplicate with standard 
deviation values lower than 10%. 
Moreover, in order to obtain a long-life preparation of NHs, thus improving the 
industrial appeal of such systems, a cryoprotectant solution (1 % w/V dextrose) 
was added to the drug-loaded NHs, due to the fact that cryoprotection with 
sugars significantly enhanced the ability to re-suspend nanoparticles after freeze-
drying without aggregation. The so formed sterile NHs were then freeze-dried and 
stored for several months. The Figure 9 shows that the drug-loaded systems 
developed in this work resulted to be stable at freeze-drying process and 
subsequent re-hydration. 
 
Figure 9. Average dimensions of drugs-loaded NHs as a function of time before (in blue) and after (in 
red) freeze-drying and re-hydratation. Samples were analyzed in triplicate with standard deviation 
values lower than 10%. 
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Finally, with the aim to have a prolonged blood circulation of these 
nanostructures, a PEG-HA220-c-Rfv 60/40 product was synthetized as described in 
2.10, from the previous derivative HA220-c-Rfv 60/40 (60% of substitution degree 
with Prop moieties and 40% of Rfv coupling on it). This polymer presented less 
than  20% of propargylic moieties that we used to couple a PEG-N3 via 
azide/alkyne click chemistry reaction.  
NHs of the PEGylated derivative were obtained and analyzed in terms of size and 
ζ-potential.  
PEG-HA220-c-Rfv 60/40 based NHs (at concentration of 1 and 2 mg/ml) did not 
showed an increasing in term of size, compared to the HA220-c-Rfv 60/40 based 
NHs.  In fact, a size of 232 ± 5 nm was measured for the one prepared with the 
HA220-c-Rfv 60/40, and of 239 ± 3 for the PEGylated polymers.  
Nevertheless, a change in terms of ζ-potential was noticed (Figure 10). 
 
Figure 10. Average ζ-potential of the NHs obtained with the HA220-c-Rfv 60/40 and its PEG-derivative 
at 1 mg/ml in water. Data points are average values. Error bars indicate standard deviations (n=3). 
As expected, the NHs formed with the PEG-derivative polymer showed a less 
negative ζ-potential value (-27.9 ± 1.2 mV) that the ones formed with the HA220-c-
Rfv 60/40 polymer (-50.6 ± 0.5), suggesting that the click coupling of the azido-
PEG was successful. Moreover, 1H NMR spectra of the PEGylated polymer 
registered in D2O confirmed the presence of the PEG showing its typical intense 
signal at 3.57 ppm. A correct quantification of the linked PEG was not possible due 
to the fact that this signal resulted more intense than the HA signals.  
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2.4 Conclusions  
Amphiphilic HA-c-Rfv polymers were synthesized starting from HA with different 
Mw (57, 115, 220 and 280 kDa), that were previously modified with a propargylic 
portion, suitable for the coupling of the azido-derivative of riboflavin via click 
chemistry reaction. The obtained derivatives were characterized in terms of 
degree of substitution (DS) obtained with the Prop and RfvN3 portions, and in 
terms of the ability to form self-assembled NHs. A new method to obtain NHs was 
tested, i.e. the autoclaving process, that generate in one-step spontaneously 
sterile NHs obtained by self-assembling of the polymer chains under thermal 
treatment. HA220-c-Rfv derivatives were chosen for further investigations as NHs 
constituents for drug delivery applications. In particular, HA220-c-Rfv 40-40 NHs 
suspensions showed a size of 162 ± 10 nm, a PDI of 0.2 ± 0.05 and a ζ-potential of 
about −50 mV. These formulation resulted be stable in water at 4°C for more than 
two months, whereas at 37°C in glycerol/Simulated Intestinal Fluids (SIF) (pH 7.4) 
media, NHs resulted stable for 48 hours. Piroxicam, dexamethasone and paclitaxel 
were chosen as model drugs tested for the encapsulation into such NHS, resulting 
in an increase of their apparent water solubility of 12, 3 and 25-fold respectively, 
confirming that these NHs indeed act as solubility enhancers. Moreover, the drug-
loaded systems developed resulted to be stable for at least two months, and 
easily re-constituted after the freeze-drying process and subsequent re-hydration.  
Finally, HA220-c-Rfv 60-40 derivative was subsequently conjugated with PEG-N3 by 
Copper(I)-catalyzed Azide-Alkyne Cycloaddition (CuAAC), due to the fact that this 
derivative presented propargylic moieties still available for click coupling, thus 
potentially improving the blood circulation of these nanostructures.   
The click chemistry reaction was indeed a good synthetic strategy to easily modify 
the HA polymer chains, resulting in good yields, fast reaction and quantitative 
conversion of the RfvN3 and PEG-N3 grafted to the polymer backbone.  
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ABSTRACT: Micellar nano-assemblies composed of thermosensitive amphiphilic 
block polymers are formed spontaneously above their CMC. For these types of 
polymers, the aqueous solubility properties depend on temperature, and micellar 
nanostructures are formed by self-assembly above their lower critical solution 
temperature (LCST) in aqueous media. For this purpose, poly N-
isopropylacrylamide (pNIPAAm) block-copolymers were synthesized by free 
radical polymerization using a polyethylene glycol based macroinitiator. Upon 
dissolution in aqueous solvents and heating above the LCST, these polymers are 
able to form micelles. To stabilize these micelles, functional groups facilitating π-π 
stacking interactions were introduced into the polymers. For this purpose, 
riboflavin as aromatic moiety was coupled to the polymer backbone by azide-
alkyne “click chemistry” reaction.  
  Two block-copolymers, methoxy poly(ethylene glycol)-b-(N-
isopropylacrylamide)-co-(2-azidoethyl) methacrylate (mPEG-b-p(NIPAAm)-co-
AzEMA) and the corresponding derivative methoxy poly(ethylene glycol)-b-(N-
isopropylacrylamide)-co-(2-azidoethyl) methacrylate-riboflavin (mPEG-b-
p(NIPAAm)-co-AzEMA-Rfv), were synthesized and  compared in terms of physico-
chemical properties, micelle size, drug retention and release.  Micelles were 
formed by heating the polymeric aqueous solution from 0 to 50°C, and paclitaxel 
(PTX) was encapsulated by mixing a concentrated drug solution in ethanol with 
the polymer solution in phosphate buffer followed by heating. Three different 
feed PTX loadings (feed drug loading concentration of 5, 10 and 20%) were tested 
in micelles of both block-copolymers.  
  Upon introduction of riboflavin in the polymeric backbone, a lower critical 
micelle temperature was obtained by (26°C for mPEG-b-p(NIPAAm)-co-AzEMA  
and 24° C for the corresponding riboflavin containing polymer, respectively). An 
average size of ~50 nm for the mPEG-b-p(NIPAAm)-co-AzEMA  and ~90 nm for the 
mPEG-b-p(NIPAAm)-co-AzEMA-Rfv micelles in water was observed respectively 
for empty micelles, which increased with ~20 nm  in phosphate buffered saline.  
Drug loading resulted in an increase of the micelle size by approximately 10-20 nm 
(from 60 to 75 nm for mPEG-b-p(NIPAAm)-co-AzEMA based micelles, and from 
150 to 170 nm for mPEG-b-p(NIPAAm)-co-AzEMA-Rfv based ones). Increased 
encapsulation efficiency (EE%) and drug loading  (DL%) were obtained for micelles 
containing riboflavin; almost 100%  encapsulation of PTX was found for a feed PTX 
loading of 5% . Nevertheless, drug release resulted be faster for the Rfv-derivative 
backbone based micelle, likely due to their lower polymer density.  
  Overall, this novel Rfv containing system is very promising in bringing advantages 
with regard to drug loading, warranting further investigations in tunability of drug 
release profiles for further application in stimuli-responsive anticancer therapy.  
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3.1 Introduction 
Micellar nano-assemblies composed of amphiphilic block copolymers are formed 
spontaneously above their critical micelle concentration (CMC), which depends on 
the hydrophobicity/ hydrophilicity balance of the block copolymers, as well as 
their molecular weight, the length of the hydrophobic block, and chemical 
characteristics of the blocks (in terms of their chemical nature).1, 2 The size of the 
polymeric micelles  in general is between 10 and 200 nm depending on the 
molecular weight of the different blocks.3  
In general, micellar structures in aqueous media consist of a hydrophobic core and 
hydrophilic corona (often composed of poly ethylene glycol (PEG)).  The 
hydrophobic nature of the core give advantages on  carrying hydrophobic 
molecules with ideally high loading capacity, and controlled release of 
encapsulated drug; the hydrophilic corona shields the hydrophobic cores, 
prevents particle precipitation in aqueous environment, and prolongs the blood 
circulation of these nanostructures.4 
The use of polymeric micelles as carriers can benefit control over important 
biological characteristic such us pharmacokinetic profile, favorable 
biodistribution, extended circulation time of the drug.  
For these kinds of polymeric systems, usually the CMC results be lower than, for 
example, the ones prepared with the conventional detergents, or compared to 
the lipid-core micelles,1 resulting in higher stability and versatility of the 
developed systems. 
   In the last decade, thermosensitive polymers have received great interest for 
the preparation of micelles,5,6 for which the aqueous solution properties are 
temperature dependent. Below their lower critical solution temperature (LCST), 
these polymers are in expanded state and fully dissolved because of the formation 
of hydrogen bonds between water and polymer molecules, while above their 
LCST, the polymeric chains are de-hydrated because of the disruption of the 
hydrogen bonds with water and consequently they collapse. If there is a good 
balance between the lengths of the hydrophobic and the hydrophilic blocks, the 
collapsed polymer forms nanostructures, whereas if the hydrophobic block is too 
long, the polymer precipitates in water in for example rods or lamellae-like 
morphology.53  
Stimuli-responsive polymers, in particular systems based on poly(N-
isopropylacrylamide) (pNIPAAm) have been extensively investigated for 
pharmaceutical and biomedical applications. pNIPAAm has a good aqueous 
solubility below its cloud point (CP), but above its CP it precipitates. This phase 
transition is reversible.7-9 The strategy to use thermosensitive polymeric micelles 
propose to obtain temporal control of the release of the encapsulated drug:  
changing the temperature of the environment even only slightly above or below 
the CP can result in destabilization of the micelles and affect the release of the 
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encapsulated drug. In other words, the drug release could be temperature 
controlled.20 
The CP of NIPAAm in water is 30-33°C, which can be tuned by copolymerization of 
NIPAAm with hydrophilic or hydrophobic monomers.10, 11 AB block copolymers of 
pNIPAAM and a hydrophilic block (such as polyethylene glycol, PEG) forms 
micelles with NIPAAm as core and the hydrophilic corona of PEG above the CP. On 
the other hand, when pNIPAAm is polymerized with hydrophobic block, it can act 
as the shell of the formed micelles below its CP.12  For both cases, micelles can be 
destabilized by hypo-hyperthermia in order to release an entrapped drug .                                  
   Unfortunately, many studies of drug-loaded micelles showed rapid drug release 
in the circulation, mostly due to a combination of extraction of the drug from the 
micelles and micellar destabilization.13  
To stabilize such micelles, researchers have developed methods of covalent cross-
linking of shells, interface or core. However, chemical conjugation methods are 
not always feasible, due the toxicity of some crosslinking agents and due some 
side reactions that can happen during the process that might affect the 
therapeutic properties of conjugated drugs. Alternatively, physical interactions, 
such as π−π stacking,14-17 hydrogen bonding 18 or stereocomplex formation 19 have 
been investigated to improve the thermodynamic and kinetic stability of 
polymeric micelles.  
Y. Shi et al.51 synthesized thermosensitive amphiphilic block copolymers with 
novel aromatic monomers by free radical polymerization of N-(2-
benzoyloxypropyl methacrylamide (HPMAm-Bz) or the corresponding naphthoyl 
analogue (HPMAm-Nt), with N-(2-hydroxypropyl) methacrylamide monolactate, 
using a polyethylene glycol based macroinitiator. Using these polymers, micelles 
were prepared with the aim to stabilize them byπ−π interactions and thereby 
increase their loading capacity for chemotherapeutic drugs.  They concluded that 
the π−π stacking effect introduced by aromatic groups indeed increased the 
stability and loading capacity of their polymeric micelles.  Inspired by that work, in 
the present study we attempted to introduce Riboflavin as π−π stacking moiety, 
and hypothesized that such isoalloxazine compound might give rise to a stable 
micellar nanostructure.  
   Riboflavin (Rfv) or Vitamin B2 is an interesting molecule with attractive 
properties21 such as biological activity as coenzyme for the flavoenzymes Flavin 
adenine dinucleotide (FAD) and Flavin mononucleotide (FMN) and their 
participation in a range of redox reactions,22  light sensitivity originating from its 
isoalloxazine ring responsible for its UV absorption, fluorescence and 
photosensitivity. Due to these characteristics, Rfv attracted attention of multiple 
scientific studies in tissue and bio-electronic engineering,23,24 targeted drug 
delivery and nanotechnology such as functionalized nanoparticles,25-27 
dendrimers,28-30 polymers, biomacromolecules31,32 and hydrogels. The 
isoalloxazine ring is well known to have a high propensity for forming charge-
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transfer complexes with biologically aromatic compounds. Moreover, the π-
bonding capability of the flavin ring, together with its hydrogen-bonding ability, 
significantly affects the physicochemical properties of crystalline riboflavin 
compounds.33   
The aim of this study was to develop new thermosensitive amphiphilic block 
copolymers, making use of the beneficial properties of riboflavin that self-
assemble into stable micelles at body temperature and exhibit high drug loading 
capacity and retention. For these purposes, methoxy poly(ethylene glycol)-b-(N-
isopropylacrylamide)-co-(2-azidoethyl) methacrylate (mPEG-b-p(NIPAAm)-co-
AzEMA) block copolymer was synthesized by free radical polymerization.20 
Subsequently, a propargyl derivative of riboflavin (Rfv-Prop) was synthesized and 
covalently coupled to the azide modified diblock copolymers mPEG-b-p(NIPAAm)-
co-AzEMA by Copper(I)-catalyzed Azide-Alkyne Cycloaddition (CuAAC), due to the 
high efficacy and selectivity of this kind of reaction.33-36  
The polymer mPEG-b-p(NIPAAm)-co-AzEMA, and its corresponding derivative 
methoxy poly(ethylene glycol)-b-(N-isopropylacrylamide)-co-(2-azidoethyl) 
methacrylate–riboflavin (mPEG-b-p(NIPAAm)-co-AzEMA-Rfv) were investigated 
and characterized in terms of coupling efficiency of Rfv, and were compared in 
terms of critical micellar temperature and concentration variation. Polymeric 
micelles were formed by heating the aqueous polymeric solutions and analyzed in 
terms of size/concentration dependent. Furthermore, those micelles with and 
without aromatic moieties in the hydrophobic core were used to loading the first-
line anticancer drug Paclitaxel (PTX), in order to study the retention and the 
release profile of such a poorly water-soluble model compound. 
   Paclitaxel is a potent drug used extensively in breast, ovarian and lung cancer.54 
The hydrophobic nature of this drug is a serious hurdle in its efficient formulation 
and restricts its use in aqueous based solvent systems. In view to overcome these 
limitations, several PTX-loaded nanoformulations were already investigated and 
well described in literature.37-42 These nanoscale drug formulations have 
demonstrated several merits, such as prolonged circulation time, better 
pharmacological profiles, decreased adverse effects and improved drug tolerance, 
over conventional clinical approaches. On this purpose, with this work we aimed 
to obtained advantages, such as in terms of loading of this drug in the lipophilic 
core (represented by riboflavin) of our micelle, exploiting hydrophobic 
interactions and the potential π-π stacking interactions that might exist between 
the aromatic rings of riboflavin and the drugs molecule (containing aromatic rings 
as well). 
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3.2 Materials and Methods 
 
3.2.1 Materials  
N-isopropylacrylamide (NIPAAm), poly(ethylene glycol) monomethyl ether (PEG, 
number-average molar mass Mn = 5000 g mol-1), sodium azide (NaN3), 2-
bromoethanol, magnesium sulfate (MgSO4), sodium bicarbonate (NaHCO3), 
sodium chloride (NaCl), 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU), propargyl 
bromide solution 80 wt. % in toluene, anhydrous sodium sulfate (Na2SO4),  
ethylenediaminetetraacetic acid disodium salt dihydrate (EDTA), copper(II) sulfate 
(CuSO4) and L-ascorbic acid were purchased from Sigma-Aldrich (Zwijndrecht, The 
Netherlands). Riboflavin tetrabutyrate was purchased from TCI Europe. Phosphate 
buffered saline pH 7.4 (PBS, in 1000 ml: NaCl 8.2g, Na2HPO4 12H20 3.1g, NaH2PO4 
2H2O 0.3g, water for injection) was obtained from B. Braun Melsungen AG 
(Melsungen, Germany). Paclitaxel (PTX) was purchased from LC Laboratories (MA, 
U.S.A.). Acetonitrile (ACN), dichloromethane (DCM), acetone, diethyl ether, ethyl 
acetate, hexane and N,N-dimethylformamide (DMF) were supplied by Biosolve 
Ltd. (Valkenswaard, The Netherlands). 
 
3.2.2 Synthesis of methoxy poly(ethylene glycol)-4,4-azobis-(4-cyanopentanoic 
acid) macroinitiator (PEG2-ABCPA)  
Methoxy poly(ethylene glycol)- 4,4-azobis- (4-cyanopentanoic acid) (mPEG2-
ABCPA) macroinitiator (Mn of mPEG = 5000 g·mol−1) was prepared as described 
previously.43 In short, 2 g (0.4 mmol) of poly(ethylene glycol) monomethyl ether 
(PEG, number-average molar mass Mn = 5000 g mol-1), 0.056 g (0.2 mmol) of 4,4-
azobis- (4-cyanopentanoic acid) (ABCPA), 0.0189 g (0.06 mmol) of 4-
(dimethylamino)pyridinium-4-toluenesulfonate (DPTS), and 0.125 g (0.6 mmol) of 
N,N′-dicyclohexylcarbodiimide (DCC) were dissolved in 1:1 mixture of DCM and 
dry DMF (final volume 30 ml). The mixture was stirred at room temperature for 24 
h. After purification by extraction and precipitation, the product was obtained in a 
high yield (∼ 80%) and characterized by 1H NMR and gel permeation 
chromatography (GPC).  
1HNMR (CDCl3) δ (ppm) 1.7 (CH3, s), 2.4 (CH2CH2COOH, br), 3.6 (CH3OCH2CH2, br, 
PEG).  
Additionally, to confirm the substitution degree of the PEG, a few drops of 
trichloroacetyl isocyanate (TAIC) were added to the NMR tube and the sample 
was analyzed again in order to confirm the calculated degree of substitution, since 
TAIC induces a shift of the CH2 protons adjacent to the OH-end groups to 4.37 
ppm. GPC analysis was performed (two serial PLgel 5 m MIXED-D column, PEGs 
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narrow molecular weights standards, DMF plus LiCl 10 mM eluent) to evaluate the 
molecular weight of the product, and the ratio between the bi-, mono- and non-
functionalized products.  
 
3.2.3 Synthesis of 2-azidoethanol 
Following a slightly modified published procedure,44 2-azidoethanol was prepared. 
In short, NaN3 (23.4 g, 360 mmol) and 2-bromoethanol (27.0 g, 216 mmol) were 
dissolved in a mixture of acetone (50 mL) and water (80 mL) and refluxed at 75 °C 
for 3 days. After removing acetone under vacuum, the product was 5 times 
extracted with 100 ml of ethyl acetate. The organic phase was dried using 
anhydrous MgSO4 and the solvent was removed by evaporation, resulting in 10.4 
g of a slightly yellow oil of product (Yield ~ 55%). 
1HNMR (CDCl3) δ (ppm) 1.8 (OH, br), 3.4 (CH2N3, t), 3.8 (CH2OH, t). 
 
3.2.4 Synthesis of 2-azidoethyl methacrylate (AzEMA) 
AzEMA monomer was prepared using a slightly modified published procedure.45  
In brief, 2-azidoethanol (2.0 g, 23 mmol) and triethylamine (3.8 ml, 27 mmol) 
were dissolved in 40 ml dichloromethane and cooled in an ice bath. Next, 
methacryloyl chloride (2.6 g, 25 mmol) dissolved in 15 ml DCM was added 
dropwise for 20 min. The reaction was allowed to proceed for 2 h at room 
temperature. Next, 30 ml of saturated NaHCO3 aqueous solution was added and 
the mixture was stirred for 30 min in an ice bath to deactivate excess 
methacryloyl chloride. The organic phase was washed with 30 ml of a saturated 
NaCl solution once, dried using anhydrous MgSO4, and concentrated under 
reduced pressure. The crude product was purified by flash silica gel 
chromatography (Silica gel 60, 0.030-0.075 mm) with DCM as an eluent, resulting 
in 2.59 g of 2-azidoethyl methacrylate as slightly yellow oil (Yield ~ 73%). 
1H NMR (CDCl3) δ (ppm) 1.89 (CH2C(CH3)CO, s), 3.43 (CH2N3, t), 4.25 (CH2CH2N3, t), 
5.55 and 6. 08 (CH2C(CH3)CO, s).   
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3.2.5 Synthesis of 3-propargyl-riboflavin tetrabutyrate (Rfv-Prop)  
Riboflavin tetrabutyrate (1 g, 1.83 mmol) was dissolved in anhydrous DMF under 
Ar2 atmosphere and heated to 55°C. Then DBU (3 eq, 837 mg, 5.5 mmol) and 
propargyl bromide (2 eq, 915 mg, 3.67 mmol) were added. After 48 h, the organic 
solvent was evaporated under reduced pressure. Water (100 ml) was added to 
the crude product, which was further extracted 3 times with diethyl ether (100 
ml) and washed with brine (100 ml). Combined organic layers were dried over 
Na2SO4, filtered and the solvent was evaporated under reduced pressure. The 
crude product was purified using a silica column (ethyl acetate/hexane, 1/1 to 
10/0, v/v) to yield 1.02 g of orange solid. (Yield ~ 94%). 
1H NMR (CDCl3) δ (ppm) 8.02 (s, 1H), 7.56 (s, 1H), 5.67 (br s,1H), 5.43(m, 2H), 4.85 
(s, 2H), 4.47 (d, 1H), 4.23 (dd, 1H), 4.09 (t, 2H), 2.54 (s, 3H), 2.42 (s, 3H), 2.28 (t, 
2H), 2.03 (m, 1H), 1.87 (m, 3H), 1.74–1.67 (m, 10H), 1.65 (dd, 2H), 1.52–1.24 (m, 
6H), 0.96 (q, 6H), 0.92(t, 3H), 0.59 (t, 3H).  
FT-IR (KBr) 2964, 2936, 2874, 2100, 1745, 1663, 1550, 1158.  
ESI–MS (+) m/z 695, 717 [M + Na]+. 
 
3.2.6 Synthesis of methoxy poly(ethylene glycol)-b-(N-isopropylacrylamide)-co-
(2-azidoethyl) methacrylate (mPEG-b-p(NIPAAm)-co-AzEMA) 
mPEG5000 –b-pNIPAAm block copolymer containing AzEMA monomers was 
synthesized by free radical polymerization using NIPAAm and AzEMA as 
monomers, and PEG2-ABCPA as macroinitiator.43 
In short, 150 mg of PEG2-ABCPA, 569.5 mg of NIPAAm and 39.06 mg of AzEMA 
were dissolved in 10 ml of dry ACN under N2 atmosphere for 20 minutes and then 
left to polymerize at 70 °C for 40 h under stirring. After cooling the mixture to 
room temperature, the formed polymer was precipitated in cold diethyl ether for 
3 times, dried under high vacuum and collected as a white solid. (Yield ~ 93%) 
1H NMR (CDCl3) δ (ppm) 1.11 (CHCH3CH3, s – NIPAAm), 3.62 (CH3OCH2CH2, br, 
PEG), 3.97 (CHCH3CH3, s – NIPAAm), 4.20 (CH2CH2N3, t, AzEMA) 
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3.2.7 Synthesis of methoxy poly(ethylene glycol)-b-(N-isopropylacrylamide)-co-
(2-azidoethyl) methacrylate-riboflavin via Click Chemistry (mPEG-b-p(NIPAAm)-
co-AzEMA-Rfv) 
mPEG-b-p(NIPAAm)-co-AzEMA (300 mg, corresponding to 0.099 mmol AzEMA) 
and Rfv-Prop (62.53 mg, 0.099 mmol Rfv-Prop) were dissolved in 6 ml of DMF. 
Then CuSO4 (57 mg, 1 eq to RfvProp) and Ascorbic Acid (63.36 mg, 1 eq to CuSO4) 
were dissolved in 300 l of H20 and added to the mixture. 
The reaction was carried out under N2 atmosphere at 40°C  for 48 h, and the 
product was then precipitated in an excess of diethyl ether, collected by 
centrifugation, dissolved in water and then dialyzed first against a EDTA solution 
10 mM of for 3 h, and then against water for at least 24 h, and finally recovered 
by freeze-drying. (Yield ~ 87%)  
1H NMR (CDCl3) δ (ppm) 1.11 (CHCH3CH3, s – NIPAAm), 3.62 (CH3OCH2CH2, br, 
PEG), 3.98 (CHCH3CH3, s – NIPAAm), 7.55 (1H, s – Rfv), 7.87 (1H, s - triazolic ring), 
7.97 (1H, s – Rfv).   
 
3.2.8 Characterization of mPEG-b-p(NIPAAm)-co-AzEMA  and mPEG-b-
p(NIPAAm)-co-AzEMA-Rfv Block Polymers  
The synthesized polymers were characterized by 1H NMR and Gel Permeation 
Chromatography (GPC) analysis in order to obtain information about the number 
average molecular weight (Mn), weight average molecular weight (Mw) and 
polydispersity (PDI, equal Mw/Mn); information about the qualitative conversion 
of AzEMA monomer, and quantitative estimation of Rfv-functionalization. 
FT-IR ATR analysis was performed in order to monitor the outcome of the click 
coupling reactions and of the purification process 
1H NMR spectra were recorded using Agilent 400 MHz spectrometer, using CD3Cl 
as solvent (solvent signal at 7.26 ppm). The value of the signal of the mPEG at 3.62 
ppm was normalized for 455 protons (average number of the protons per one 
mPEG chain Mn = 5000) and was used as reference signal. Based on this 
normalization, the signal of NIPAAm at 3.98 ppm was integrated to calculate the 
number of NIPAAm units per polymer. In addition, the signal at 1.12 ppm is 
related to the NIPAAm protons, and the calculation was confirmed for this peak as 
well.  
GPC analysis was performed using two serial PLgel 5 m MIXED-D columns and 
PEGs of narrow molecular weights as calibration standards. The eluent was DMF 
plus LiCl 10 mM, a flow rate of 1 ml/min was used at a column temperature of 60 
°C. The GPC chromatograms were deconvoluted to calculate the weight ratio. The 
deconvolution was performed by Empower systems software produced by Waters 
Corporation (Milford, Massachusetts, USA).  
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FT-IR were measured using a Bio-Rad FTS6000 (BIO-RAD, Cambridge, 
Massachusetts, USA) in ATR mode. A spectral resolution of 4 cm− 1 with 64 co-
added scans was used for collection of reference spectra over a spectral range of 
4000–600 cm− 1. 
 
3.2.9 Cloud Point (CP)  
The CPs of the block-co-polymers were measured by two different techniques: 
differential scanning calorimetry (Discovery DSC-TRIOS data analysis, TA 
instruments, New Castle, Delaware, USA) and light scattering at 550 nm by Jasco 
FP8300 Spectrofluorometer (Jasco Inc., Easton, Maryland, USA).  
DSC analysis was performed to investigate the lower critical solution temperature 
(LCST) of the synthesized copolymers. All the samples were prepared by dissolving 
the block copolymers overnight at 4 °C at a concentration of 5 wt% in 0.1 M PBS 
buffer, pH 7.4. Into aluminum sample pans, 20 L of these solutions were 
transferred and the pans were hermetically capped. Thermograms were recorded 
in triplicate from 0 to 80 °C, using a heating rate of 1 °C/min.  
To confirm the data obtained from the DSC analysis, the following procedure was 
performed in order to determinate the cloud point of the block copolymers based 
on the intensity changes of scattered light from the polymers upon increasing 
temperature. The samples were prepared by dissolving the polymers overnight at 
4 °C in a concentration of 10 mg/ml  in 0.1 M PBS buffer, pH 7.4 and then diluted 
to a final concentration of 1 mg/ml. The samples were excited at 550 nm and the 
light scattering intensity values were registered from 5 to 55 °C, using a heating 
rate of 1 °C/min. The light scattering intensity was plotted against a temperature 
rate and the onset on the X-axis, obtained by the extrapolation of the Light 
Scattering Intensity-Temperatures curves to the baseline, was considered as the 
cloud point. 
 
3.2.10 Preparation of Empty and Drug Loaded Micelles 
Empty micelles were prepared by fast heating procedure.48 In short, the polymers 
were dissolved in water or in PBS at 4 °C overnight at concentrations of 0.5, 1, 2 
and 3 mg/ml. Subsequently, the polymer solutions were heated to 50 °C for 1 min 
in a water bath while stirring. The samples were then cooled down to 37 °C and 
analyzed in terms of size and polydispersity by DLS. DLS was performed using a 
Malvern CGS-3 multiangle goniometer with JDS Uniphase 22mW He-Ne laser 
operating at 632 nm, an optical fiber-based detector and a digital LV/LSE-5003 
correlator (Langen, Germany).  Autocorrelation functions were analyzed by the 
cumulants method (fitting a single exponential to the correlation function to 
obtain the mean size and the PDI) and the CONtIN routine (fitting multiple 
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exponential to the correlation function to obtain the distribution of the particle 
sizes). All the measurements were performed at 90 ° angle.  
For paclitaxel loaded micelles, 20 l of drug solutions in ethanol (drug feed 
loading concentration of 5, 10 and 20 % w/V) were added to 2 ml of ice cold 
polymer solutions in PBS (polymer concentration of 1 mg/ml) and then 
immediately heated at 50 °C for 1 min while shaking. Subsequently, the micellar 
dispersions were incubated overnight at 37 °C. Non-encapsulated drug was 
removed by centrifugation (5000 g, 37 °C, 10 min) and the micelles were analyzed 
in terms of size by DLS measurement. The PTX content in the micellar dispersion 
was quantify by HPLC method, as well aliquots at different time slots were taken 
and analyzed in order to follow the release profile of the drug. 
 
3.2.11 Drug content assay and drug retention study 
The concentration of the drug loaded in the micelles was evaluated by isocratic 
HPLC chromatography, using a C18 SunFire (5 m, 4.6*150 mm) column and a 
mixture of ACN/water (60/40) and perchloric acid 0.1 % V/V, as eluent at flow rate 
1 ml/min. The detection was performed by UV detector at 227 nm. Drug loaded 
micelles were diluted 9 times with ACN and subsequently vortexed to destabilize 
the micelles and dissolve the drug.  Samples of drug in ACN in a concentration 
range of 0.2 to 100 g/ml were used as standards for the calibration.   
Encapsulation Efficiency (EE) and Drug Loading (DL) were calculated from the 
HPLC analysis data based on these equations:  
 
%𝐸𝐸 =  
𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 𝑜𝑓 𝑑𝑟𝑢𝑔 𝑚𝑒𝑎𝑠𝑢𝑟𝑒𝑑 
𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 𝑜𝑓 𝑑𝑟𝑢𝑔 𝑎𝑑𝑑𝑒𝑑
 𝑥 100 
 
%𝐷𝐿 =  
𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 𝑜𝑓 𝑑𝑟𝑢𝑔 𝑚𝑒𝑎𝑠𝑢𝑟𝑒𝑑 
𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 𝑜𝑓 (𝑑𝑟𝑢𝑔 𝑚𝑒𝑎𝑠𝑢𝑟𝑒𝑑 + 𝑝𝑜𝑙𝑦𝑚𝑒𝑟 𝑎𝑑𝑑𝑒𝑑)
 𝑥 100 
 
Drug retention in the micelles at pH 7.4 in phosphate buffer at 37 °C was studied 
by measuring the remaining drug content in the micellar dispersion in time. For 
the release study, aliquots of PTX-loaded micelles prepared as described 
previously and incubated at 37 °C, were taken at different time points. Each 
aliquots was centrifuged (5000 g for 10 min at 37 °C) to spin down the released 
PTX crystallized because of its low water solubility (PTX water solubility 5.56 
g/ml). Subsequently, 9 parts of ACN were added at the aliquots, vortexed and 
injected to evaluate the amount of the residual drug retained in micelles (drug 
concentration was evaluated by HPLC method as described previously).  
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3.3 Results and Discussion 
 
3.3.1 Synthesis of methoxy poly(ethylene glycol)-4,4-azobis-(4-cyanopentanoic 
acid) (PEG2-ABCPA) macroinitiator  
Monomethoxy-PEG substituted macroinitiator (PEG2-ABPCA) was synthesized as 
shown in the following reaction scheme (Scheme 1)43 in order to obtain AB block 
copolymers by free radical polymerization composed of PEG as block A.  
 
HO
N
N
OH
O
CN
CN
O
H3CO
O
H
n
DPTS, DCC
CH2Cl2/DMF
24h / RT
O
N
N
O
O
CN
CN
O
ABCPA mPEG PEG2-ABCPA
O
CH3OH3C
 
Scheme 1. Synthesis of PEG2-ABPCA macroinitiator. 
 
The product was obtained in a high yield (∼ 80%), after precipitation in cold 
diethyl ether as white solid powder, and analyzed by 1H NMR and GPC analysis.  
To evaluate if the substitution of the PEG was successful and complete, an easy 
and fast analysis was performed based on 1H NMR spectroscopy after addition of 
trichloroacetyl isocyanate (TAIC) to the NMR sample, suggested by R. De Vos et 
al.40, used to test the end groups of a series of commercial PEG monomethyl 
ethers. TAIC was used as reagent to identify unreacted free hydroxyl groups by 
transforming them to trichloroacetyl urethane-end groups, which can be easily 
identified by 1H NMR spectroscopy because the urethane derivative causes a shift 
(from 4.23 to 4.37 ppm) of the methylene protons in α-position of the OH end 
groups. The integrals of the two signals (4.23 ppm relative to the PEG-
macroinitiator; 4.37 ppm relative to the PEG- trichloroacetyl urethane) are 
directly related to the relative amount of functionalized and non-functionalized 
PEG. 
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The functionalization degree determined was 76%. (Figure 1) 
 
A)                                                                             B) 
  
Figure 1. 1H NMR spectra in CDCl3 of (A) PEG-macroinitiator and (B) PEG-trichloroacetyl uretane. 
 
GPC analysis was performed to evaluate the molecular weight of the product and 
the ratio between the bi and mono-functionalized products. The chromatogram 
(Figure 2) showed 2 peaks, peak A with a retention time of 14 min (Mn 10 kDa) 
and peak B with a retention time of 14.9 min (Mn 5 kDa). Based on calibration 
using PEGs of known molecular weight, peak A was assigned to the bi-
functionalized product (PEG2-ABPCA) and peak B is assigned to the mono-
functionalized product (PEG-ABPCA) and non-functionalized PEG.  
12 13 14 15 16 17
Peak B
Time (min)
Peak A
 
Figure 2. GPC chromatogram of PEG2-ABPCA macroinitiator, which shows peak A (retention time 14 
min) corresponding to the PEG2-ABPCA product, and peak B (retention time 14.9 min) corresponding 
to PEG-ABPCA and non-functionalized PEG.  
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The areas under the curves of the two peaks give us the ratio of the two 
compounds. Accordingly, in this synthesized batch, the percentage of bi-
functionalized PEG (PEG2-ABPCA) resulted to be 57%, and 43% consisted of the 
mono-functionalized one (PEG-ABPCA) and non-functionalized PEG. 
 
3.3.2 Synthesis of 2-azidoethyl methacrylate (AzEMA) monomer 
AzEMA monomer was synthesized as shown in the following reaction scheme 
(Scheme 2), from a two-step synthesis by conversion of 2-bromoethanol to 2-
azidoethanol by a nucleophilic substitution of the bromide with an azide group, 
and its subsequent methacrylation using methacryloyl chloride.  
HO
Br
NaN3
H2O/ Acetone
75°C, 3 days
HO
N3
Cl
O
Et3N, CH2Cl2
RT
O
N3
O
AzEMA2-Bromoethanol 2-Azidoethanol  
Scheme 2. Two-step synthesis of 2-azidoethyl methacrylate (AzEMA) by conversion of 2-
bromoethanol to 2-azidoethanol and subsequent methacrylation using methacryloyl chloride. 
 
From the first synthetic step, the compound 2-azidoethanol was collected in a 
yield of 55% after extraction, and its structure was confirmed by 1H NMR analysis, 
which showed the shift of the methylene signals (-CH2N3) of the product from 3.4 
ppm (-CH2Br) to 3.3 ppm. (Spectra not shown)  
Then, the alcoholic moiety of 2-azidoethanol was reacted with methacryloyl 
chloride to couple the methacrylic moiety necessary for the next step of 
polymerization. The 2-azidoethyl methacrylate product was obtained in a quite 
high yield (~ 73%) as yellowish oil and analyzed by 1H NMR, which showed three 
additional signals at 6.10, 5.55 and 1.89 ppm of the protons corresponding to the 
methacrylate group. Moreover, the signal at 3.65 ppm (-CH2OH) of the methyl 
protons adjacent to the hydroxyl group was shifted to 4.25 ppm, confirming the 
successful esterification.  
Lastly, the infrared spectrum of the AzEMA compound showed the strong 
asymmetric vibration (N≡N asymmetric stretching absorption) at 2100 cm-1. 
(Spectra not shown) 
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3.3.3 Synthesis of methoxy poly(ethylene glycol)-b-(N-isopropylacrylamide)-co-
(2-azidoethyl) methacrylate (mPEG-b-p(NIPAAm)-co-AzEMA) block copolymer 
The mPEG-b-p(NIPAAm)-co-AzEMA block copolymer was synthesized with a 5 
mol% in content of AzEMA monomer (relative to the NIPAAm monomers) by free 
radical polymerization, using PEG2-ABPCA as macroinitiator, NIPAAm and AzEMA 
as monomers. (Scheme 3) 
H3C O
O
O
CN
NH OOO
N3
NH2O O
O
N3
PEG2-ABCPA
ACN, 70°C
NIPAAm AzEMA mPEG-b-p(NIPAAm)-co-AzEMA  
Scheme 3. Synthesis of mPEG-b-p(NIPAAm)-co-AzEMA block copolymer by free radical 
polymerization using PEG2-ABPCA as macroinitiator, NIPAAm and AzEMA as monomers. 
 
The polymer mPEG-b-p(NIPAAm)-co-AzEMA was obtained in a high yield of 
(88/90%) after purification by precipitation. Number average molecular weight 
(Mn), weight average molecular weight (Mw) and polydispersity (PDI, equal to 
Mw/Mn) were measured by GPC and 1H NMR analysis.     
1H NMR analysis of the obtained mPEG-b-p(NIPAAm)-co-AzEMA  block copolymer 
showed the mPEG signal at 3.62 ppm normalized for 455 protons and this peak 
was used as reference signal. (Figure 3) 
 
      
Figure 3. 1H NMR spectra in CDCl3 of mPEG-b-p(NIPAAm)-co-AzEMA block copolymer. Zoom-in on 
the region between 5 and 3 ppm where the PEG and NIPAAm signals can be observed. Peaks at 3.8, 
3.5 and 3.4 ppm are related to residual solvent. 
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1H NMR spectra also showed the unique signal of the AzEMA monomers at 4.20 
ppm and the ratio between PEG and NIPAm signals indicated a good conversion 
with 178 NIPAm units per polymer corresponding to a Mn of 25.1 kDa.  (Table 1) 
GPC analysis was in line with 1H NMR and showed an Mn of the polymer of 29.2 
kDa (chromatogram not shown) with a PDI (Mw/Mn) of 2.5, which is acceptable for 
free radical polymerization techniques. (Table 1) 
FT-IR analysis was performed by ATR method. The spectra clearly showed the 
strong asymmetric vibration (N≡N asymmetric stretching absorption) at 2100 cm-1 
confirming the presence of the AzEMA monomer in the polymeric chains. (Spectra 
not shown) The feed ratio AzEMA : NIPAm was 5 : 95. Unfortunately, the exact 
determination of the obtained ratio was difficult to quantify exactly with these 
methods. Nevertheless, the presence of azide moieties was proven since they 
were clearly visible in both NMR and IR.  
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3.3.4 Synthesis of 3-propargyl-riboflavin tetrabutyrate (Rfv-Prop)  
A propargyl derivative of riboflavin tetrabutyrate was synthesized as described in 
section 2.5, using DBU as base to deprotonate the nitrogen of the isoalloxazine 
ring that was afterwards alkylated using an excess of propargyl bromide (Scheme 
4).  
N
NH
N
N O
O
OR
OR
RO OR
Br N
N
N
N O
O
OR
OR
RO OR
DBU
 DMF
 55°C, 48h
Rfv Rfv-PropPropBr
R: COCH2CH2CH3
 
Scheme 4. Alkylation of riboflavin tetrabutyrate with propargyl bromide. 
 
The pure product was obtained in high yield (~94%) after extraction and 
purification by column chromatography. 
1H NMR analysis confirmed the presence of the propargyl moiety in the product. 
The spectrum (Figure 4) clearly showed the signal at 4.85 ppm assigned to the 2 
protons of the CH2 group of the propargyl moiety (-CH2C≡CH).  
 
 
 
Figure 4. 1H NMR spectrum of 3-propargyl-riboflavin tetrabutyrate (Rfv-Prop) in CDCl3. 
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3.3.5 Coupling reaction of Rfv-Prop to mPEG-b-p(NIPAAm)-co-AzEMA via Click 
Chemistry  
The coupling reaction of the Rfv-Prop derivative to  mPEG-b-p(NIPAAm)-co-AzEMA 
polymer was carried out as explained in the following reaction scheme (Scheme 
5), using CuSO4/ascorbic acid as catalysts, and aiming to functionalize all azide 
containing monomers (ratio azide:alkyne 1:1).  
PEG NIPAAm AzEMA
N
N
N
N O
O
OR
OR
RO OR
CuSO4/Ascorbic Acid
N2 atmosphere
48h / RT
mPEG-b-p(NIPAAm)-co-AzEMA-Rfv
Rfv-Prop
H3C O
O
O
CN
NH OOO
N3
H3C O
O
O
CN
NH OOO
N
N
N
N
NO
O
RO
RO
ORRO
N
N
R: COCH2CH2CH3
 
Scheme 5. Coupling reaction of Rfv-Prop to mPEG-b-p(NIPAAm)-co-AzEMA via Click Chemistry. 
The polymer was collected after precipitation in cold diethyl ether, and then 
dialyzed against EDTA solution to purify the polymer from the Cu+ ions. The 
obtained yellow polymer was analyzed by 1H NMR and GPC analysis to determine 
Mn, Mw and PDI, and to quantify the amount of riboflavin moieties coupled to the 
polymer.  
1H NMR analysis of the block copolymer revealed the signal of PEG at 3.63 ppm 
(that was integrated and normalized for 455 protons, as described above); the 
signals of  NIPAAm at 1.17 ppm (-CH(CH3)2) and 3.98 ppm (-CH(CH3)2), and the 
unique signal at 4.1 ppm of  AzEMA. Moreover, signals of Riboflavin aromatic 
protons are shown at 7.97 (s, 1H) and 7.55 ppm (s, 1H) in Figure 7. The downfield 
region of the spectra showed an additional signal at 7.87 ppm (s, 1H), assigned to 
the proton of the triazolic ring formed after the click chemistry reaction. (Figure 5) 
 
 
Figure 5. Zoom-in on the down field region of the overlap of the 1H NMR spectra of mPEG-b-
p(NIPAAm)-co-AzEMA-Rfv block copolymer (in red) and Rfv-Prop (in green) in CDCl3. 
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From this analysis, it was possible to quantify the coupling efficiency of Rfv-Prop, 
using the integration values of the signals at 7.97 (s, 1H), 7.55 ppm (s, 1H) and 
7.87 ppm (s, 1H), corresponding to the aromatic protons. The average integration 
value of these signals was 4.85, corresponding to almost 5 monomers containing 
Rfv moieties per polymer chain (and 178 NIPAm monomers, i.e. NIPAm : Rfv = 
97.2 : 2.8). From the complete 1H NMR spectrum it was possible to evaluate the 
Mn of the polymer (Table 1), based on the same considerations made for the 
previous block copolymer described in 3.2. The Mn was 25.1 kDa. GPC analysis 
performed in the same conditions as described in 2.4, gave 29.5 kDa as Mn value 
and a PDI of 6.2 (Table 1), which is very high value of polydispersity that can be 
attributed to the latent activity of the azido-groups. In fact, the azide group has 
been shown to form a highly reactive nitrene upon thermolysis or photolysis, 
which can then undergo a side reaction, resulting in crosslinking.55-59  
These side reactions can likely be limited to a certain extent by using lower 
monomer concentrations during polymerization or decreasing the polymerization 
reaction time.  
GPC analysis was performed using a refractive index detector (RI) to determinate 
the molecular weights and weight distributions of the polymer. UV dual detection 
(346 and 447 nm, corresponding to the characteristic wavelengths of Rfv 
absorptions) clearly indicated that nearly all riboflavin was covalently linked to the 
backbone (Figure 6). 
0 4 8 12 16 20 24 28
Time (min)
 mPEG-b-p(NIPAAm)-co-AzEMA-Rfv
 Rfv-Prop
UV detection @447 nm 
 
Figure 6. GPC chromatograms UV detection at a wavelength of 447 nm of free Rfv-Prop (in orange), 
and the click conjugate of mPEG-b-p(NIPAAm)-co-AzEMA with Rfv-Prop (in blue).  
The overlapping chromatograms of the polymer mPEG-b-p(NIPAAm)-co-AzEMA-
Rfv and of the free Rfv-Prop, at the same Rfv concentration, showed that at 447 
nm the free Rfv-Prop eluted at 17.9 minutes, while the polymer obtained by click 
conjugation eluted at 9.6 minutes. The GPC analysis of the conjugated showed 
that the majority of the Rfv eluted at the same retention time of the polymer (RI 
detection, retention time of mPEG-b-p(NIPAAm)-co-AzEMA-Rfv 9.8 minutes, data 
not shown). A small peak was observed at the retention time of the free Rfv-Prop, 
residue from the purification process.  
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3.3.6 Cloud Point (CP) 
The CPs of the block copolymers were measured by the intensity changes of 
scattered light from the polymers with increasing temperature. CPs of the 
synthetized polymers were obtained by measuring the light scattering intensity 
against the temperature rate and the onset on the X-axis was considered as the 
cloud point. For the mPEG-b-p(NIPAAm)-co-AzEMA block copolymer the CP found 
was 27 °C (in agreement with published data).43 For the mPEG-b-p(NIPAAm)-co-
AzEMA-Rfv polymer a CP 24 °C was found. As expected, the CP of the polymer 
with even only 2.8% of the monomers containing Rfv resulted be lower than the 
one without Rfv, which can be explained by the fact that Rfv contributes to 
increasing the hydrophobicity of the polymer chains. 
The self-assembly behavior of polymers was indeed found to be a reversible 
process with an observed cooling hysteresis attributed to the restricted mobility 
of the phase separated polymer chains. 
These data were confirmed by DSC analysis. In general, the characteristic phase 
separation temperatures have been defined as the onset of the transition 
endotherm (as the temperature at the peak of the thermogram).47 From DSC 
analysis, the LCSTs of the mPEG-b-p(NIPAAm)-co-AzEMA block copolymer found 
were 26 °C and 24 °C for the mPEG-b-p(NIPAAm)-co-AzEMA-Rfv polymer. 
The properties of both polymers obtained by 1H-NMR, DSC and light scattering 
techniques are summarized in Table 1.  
The enthalpy values obtained from the DSC analysis from the transition towards a 
dehydrated state of polymers was 1.59 J/g for the mPEG-b-p(NIPAAm)-co-AzEMA 
block copolymer, and 0.79 J/g for the mPEG-b-p(NIPAAm)-co-AzEMA-Rfv polymer, 
indicating that the polymer modified even with only  2.8% of Riboflavin containing 
monomers needs less energy to dehydrate. 
 
Table 1. Summary of the characteristics of mPEG-b-p(NIPAAm)-co-AzEMA and mPEG-b-p(NIPAAm)-
co-AzEMA-Rfv block copolymers. 
 
ND: not detected, a determined by 1H NMR, b determined by GPC, c determined by DSC, d determined by light 
scattering. 
 
 PEG:NIPAAm %AzEMA %Rfv Mn (kDa)a Mn (kDa)b Mw/Mn b LCST (°C)c CP  (°C d 
 Feed Obtained a Feed Obtained Obtained a      
mPEG-b-
p(NIPAAm)-co-
AzEMA  
1:168 1:178 5 ND - 25.12 29.2 2.5 26 27 
mPEG-b-
p(NIPAAm)-co-
AzEMA-Rfv  
    2.8 25.14 29.6 6.2 24 24 
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3.3.7 Considerations about the contribution afforded by Riboflavin frameworks 
bound at the polymer backbone to the stability of the generated micellar core 
In this study, we introduced a tetra esterified Riboflavin framework (Rfv) at the 
side chains of the outer blocks of the polymer backbone that are potentially able 
to establish effective supramolecular interactions with each other. Such 
interactions may significantly increase the stability of the final micellar 
nanostructure formed by this derivatized polymer. 
Indeed, the isoalloxazine ring of Rfv is well known to have a high propensity for 
forming charge-transfer complexes based on π−π stacking, H-bond and 
electrostatic interactions with twin molecules, or other suitable aromatic 
molecular partners.52 In general, the most stable dimeric adducts of Rfv are those 
displaying a parallel or T-shaped conformation of the aromatic planes, i.e. 
supramolecular species that are essentially isoenergetic and represent geometries 
of minimal energy.52  
Hence, we performed some preliminary molecular modeling studies, based on 
semi-empirical calculations (functional AM1), aimed to elucidate the most 
favorable supramolecular geometries that can be formed by self-assembly of 
couples of Rfv frameworks. The obtained results are shown in Figure 7, and they 
pointed out that, in principle, several reciprocal 3D dispositions of the Rfv 
frameworks showed energetically favorable interactions that could potentially 
improve the stability of the micellar core.  
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Figure 7. Minimum energy geometries of dimers of Riboflavin tetrabutyrate molecules optimized by 
molecular modeling calculations: (A) most stable adduct formed between two units of Rfv bonded to 
examples of polymeric chain: effective electrostatic interactions established between isoalloxazine 
ring and tetra-esterified ribose-moiety;  (B) more stable “plane-to-edge” disposition of two units of 
Rfv;  (C) more stable “plane-to-plane” disposition of two units of Rfv;  (D) less stable “plane-to-
plane” disposition of two units of Rfv; (E) less stable “plane-to-edge” disposition of two units of Rfv. 
 
 
 
 
 
A) 
D) 
B) C) 
E) 
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Among these, the most effective one displays a clear extensive involvement of the 
tetra-esterified ribose-moiety belonging to one of the two Rfv frameworks in the 
establishment of effective electrostatic interactions with the isoalloxazine ring 
belonging to the other supramolecular partner (Figure 7B). With respect to this 
dimeric geometry, the supramolecular association derived by the establishment of 
C-H... π interactions between the isoalloxazine rings of two units of Rfv, resulted 
be just a bit less effective, from an energetic point of view (~1.4 kcal×mol-1). In 
such a supramolecular geometry, aligned according to a “plane-to-plane” 
disposition (Figure 7C), the flavins display their pyrimidine rings aligned and 
pointing along opposite direction. On the contrary, calculations also predicted 
that much less favorable C-H... π interactions (equal to approximately 12 
kcal×mol-1) can be established if the “plane-to-edge” aligned isoalloxazine rings 
point their pyrimidine rings in opposite directions (Figure 7E). Finally, although 
less effective (for about 3.6 kcal×mol-1) than the first type of the above quoted C-
H... π recognition, also the establishment of  π…π interactions was assessed giving 
rise to an acceptable contribution able to improve the stability of the micellar 
core, providing that, in this case, the “plane-to-plane” aligned flavins point their 
pyrimidine rings in the same direction (Figure 7D).  
However, overall, it is obvious that all the above analyzed molecular dockings, 
concerning dimers of Rfv, can only be considered as strongly simplified models of 
the possible interactions that may play a role in the generation of a very complex 
micellar core system, on which the tetra-esterified form of Rfv might occupy a 
large volume. This phenomenon can contribute to the less dense structure of the 
core of the obtained micelle. Moreover, in the core of the micelles a much greater 
number of Rfv units is present, which was not taken into account in this modelling 
experiment. 
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3.3.8 Empty and drug-loaded micelles preparation and characterization 
In this work, due the thermosensitivity of the synthesized amphiphilic polymers, 
empty and drug-loaded micelles could be formed by a fast heating procedure, by 
heating the polymers solutions above their CPs. PTX was loaded by simply mixing 
of a small volume of concentrated PTX solution in ethanol with aqueous polymeric 
solutions at 4°C, subsequently heated to 50 °C in a water bath while stirring. Z-
average hydrodynamic diameters of empty micelles prepared by this method at a 
concentration of 1 mg/ml in water and PBS was detected by DLS.  
For the mPEG-b-p(NIPAAm)-co-AzEMA based micelles in water and in PBS, Z-
average were 50 and 60 nm, respectively. For micelles based on mPEG-b-
p(NIPAAm)-co-AzEMA-Rfv polymer, the mean diameters found were  90 and 150 
nm in water and in PBS respectively. This noticeable increase in micelles size in 
PBS compared to water can be attributed to a salting-out effect of ions presents in 
the buffer.48 For all the preparations, the polydispersity index was low (from 0.03 
to 0.25). Micelles prepared starting from different polymer concentrations (0.5, 1, 
2 and 3 mg/ml) in water and PBS were also analyzed in terms of size, 
polydispersity and count rate and for both the media. Remarkably the size of 
micelles based on mPEG-b-p(NIPAAm)-co-AzEMA-Rfv polymer resulted be 
concentration dependent, while the micelle size of mPEG-b-p(NIPAAm)-co-AzEMA 
was concentration independent (Figure 8). This phenomenon could be attributed 
to the fact the Rfv-derivatized polymer was partially cross-linked (as described in 
3.5) and did not dissolve properly in the aqueous media, during the sample 
preparation for the further micelles formation. 
 
A)                                                                                B) 
 
 
 
  
 
  
 
 
 
 
Figure 8. Z-Average hydrodynamic diameter of empty polymeric micelles in water (A) and PBS (B) 
media. Data points are average values. Error bars indicate standard deviations (n=3).  
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Figure 9. Encapsulation Efficiency (EE%) and Drug Loading  (DL%) of PTX-loaded micelles relative to 
the feed drug loading concentration tested of 5, 10 and 20 % w/V (PTX5, PTX10 and PTX20 
respectively). Data points are average values. Error bars indicate standard deviations (n=3).  
  
 
PTX loaded micelles were prepared as described in 3.2.10 and the micellar 
dispersions were analyzed in term of size by DLS measurements. (Table 2) 
Dispersions of PTX-loaded micelles of mPEG-b-p(NIPAAm)-co-AzEMA and mPEG-b-
p(NIPAAm)-co-AzEMA-Rfv prepared at polymer/drug ratio of 2/1, were opalescent 
and homogeneous. 
Table 2. Z-average size of empty and PTX-loaded micelles based on mPEG-b-p(NIPAAm)-co-AzEMA 
and mPEG-b-p(NIPAAm)-co- AzEMA-Rfv polymers. The size of the PTX-loaded micelles are relative to 
the feed drug loading concentration tested of 5, 10 and 20 % w/V (PTX5, PTX10 and PTX20 
respectively).  
 
*(pol. conc. 1mg/ml in PBS) 
After removing the precipitated non-encapsulated drug, the Encapsulation 
Efficiency (EE%) and Drug Loading  (DL%)  (for all the feed drug loadings tested) in 
mPEG-b-p(NIPAAm)-co-AzEMA-Rfv based micelles resulted be higher than in the 
mPEG-b-p(NIPAAm)-co-AzEMA based ones, indicating that micelles with aromatic 
groups are better capable to solubilize hydrophobic drugs such as PTX. (Figure 9) 
 
 
  
 
 
 
 
 
 
In detail, EE% of 80.3 ± 3.8, 60.2 ± 5.7 and 62.6 ± 11.6 % were obtained for  mPEG-
b-p(NIPAAm)-co-AzEMA based micelles, for the 5, 10 and 20% feed PTX loadings 
respectively. For mPEG-b-p(NIPAAm)-co-AzEMA-Rfv  based micelles, EE% values 
reached 93.7 ± 2, 77.4 ± 3.5 and 65.9 ± 3 for the three different feed PTX loadings, 
respectively.  As expected, for all formulations, the encapsulation efficiency was 
Z
ave 
± SD * Empty 
micelle 
PTX-loaded micelle 
(PTX5) 
PTX-loaded micelle 
(PTX10) 
PTX-loaded micelle 
(PTX20) 
mPEG-b-p(NIPAAm) 
-co-AzEMA  
60 ± 4 nm 71 ± 2nm 75 ± 3nm 76 ± 3 nm 
mPEG-b-p(NIPAAm) 
-co-AzEMA-Rfv 150 ± 3 nm 168 ± 3nm 175 ± 5 nm 178 ± 3 nm 
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Figure 10. Cumulative release profile (%) of PTX from mPEG-b-p(NIPAAm)-co-AzEMA and  
mPEG-b-p(NIPAAm)-co-AzEMA-Rfv  based    micelles, prepared in PBS, pH 7.4, at 37 °C.  
Data points are average values. Error bars indicate standard deviations (n=3). 
highest for the lowest feed drug loading, showing clearly that the EE% of PTX 
decreases when the feed concentration increased from 5 to 20%.  
The overall drug loading % of mPEG-b-p(NIPAAm)-co-AzEMA based micelles with 
different drug feeds were 3.8 ± 0.25, 5.7 ± 0.55 and 11.1 ± 0.54 % , and 4.5 ± 0.12, 
7.2 ± 0.75 and 11.6 ± 0.8 % for the mPEG-b-p(NIPAAm)-co-AzEMA-Rfv  based 
micelles, showing again that a more efficient encapsulation was obtained for 
micelles based on the more hydrophobic polymer. Nevertheless, the highest DL% 
value related to the starting feed drug loading, was obtained for the mPEG-b-
p(NIPAAm)-co-AzEMA-Rfv  based micelle with a 5% of feed PTX loading.   
 
3.3.9 In vitro drug release study  
Drug release from the micelles at pH 7.4 in phosphate buffer at 37 °C was studied 
by measuring the residual drug concentration into micelles dispersion. (Figure 10) 
For each PTX-loaded micelle formulation, aliquots were taken at different time 
points (2, 4, 6, 8, 12 and 24 h), which were centrifuged to spin down the released 
PTX that crystallized because of its low water solubility (5.56 g/ml). Then, for 
each aliquot the amount of the residue drug (in %) retained into micelles was 
evaluated (drug concentration was evaluated by HPCL method as described in 
3.2.11).  
   
  
  
  
   
 
 
 
 
Unfortunately, PTX was not retained for long periods of time in both types of 
micelles with a complete release within 24h. In particular, the formulations of 
20% feed drug loading were the most unstable and the drug was released fastest, 
while a lower drug feed loading resulted in a slightly slower release. Furthermore, 
the release was faster for mPEG-b-p(NIPAAm)-co-AzEMA-Rfv  formulations (for all 
the feed drug loadings tested), which can be explained  by the fact that these 
micelles were bigger, and therefore less dense than the  mPEG-b-p(NIPAAm)-co-
AzEMA based ones resulting in a faster diffusion of the drug.  
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3.4 Conclusions and Future Plans 
A thermosensitive amphiphilic block polymer consisting of mPEG-b-p(NIPAAm)-co-
AzEMA was synthetized having on average 5 AzEMA monomer per polymer. A 
propargyl derivative of Riboflavin (Rfv-Prop) was synthesized and covalently 
coupled to the azide modified diblock copolymers by Copper(I)-catalyzed Azide-
Alkyne Cycloaddition (CuAAC). Both the obtained block-copolymers self-
assembled into polymeric micelles above their characteristic CPs. The CP was 
affected by the coupling of Rfv resulting in a slightly lowered CP for the polymer 
with Riboflavin coupled to it, due to the increased hydrophobicity of the polymer. 
Also, micellar size was increased by the presence of Rfv, while the size increased 
slightly more upon loading of the poorly water-soluble anticancer drug Paclitaxel 
(PTX). Both types of micelles displayed a high Loading Efficiency, in particular 
higher for the mPEG-b-p(NIPAAm)-co-AzEMA-Rfv based micelle.  The high drug 
loading of these micelles show their potentially interesting properties for 
controlled drug release applications. In this study, we observed that the drug 
release needs optimization, which may be obtained by increasing the Rfv amount 
conjugated to the backbone, meaning further increasing in hydrophobicity and 
possibly achieving better spatial arrangement of the flavin units as displayed in 
the modeling experiments. Therefore, before considering evaluation in vivo, a 
further optimized release profile needs to be obtained followed by in vitro 
cytotoxicity tests of these formulations.  
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4.1 Summary 
   The research described in this thesis is focused on the design of two kinds of 
self-assembled nanocarriers for the delivery of hydrophobic drugs: nanohydrogels 
and micelles that both contain a hydrophobic internal domain and a surrounding 
hydrophilic shell. The development of Nano Drug Delivery Systems (NDDS) is a 
promising approach for promoting intelligent therapeutic systems to bring 
significant advances in the diagnosis and treatment of diseases, with the 
challenges to maximize therapeutic activity and to minimize undesirable side 
effects. 
   Nanogels or nanohydrogels (NHs) are hydrophilic 3D polymer networks on the 
nanoscale with a tendency to swell in water when placed in an aqueous 
environment. NHs were first defined by Kabanov and Vinogradov to describe 
cross-linked bifunctional networks of a polyion and a non-ionic polymer.1, 2  Later, 
Akiyoshi et al. described the phenomenon of physical cross-linking (self-assembly) 
of cholesterol-modified polysaccharides which resulted in formation of swollen 
hydrogels at nanoscale size.3 Since then, NHs development as functional smart 
materials for biotechnological and biomedical applications have been exhaustively 
described in literature.4-6  
   Polymeric micelles are self-assembling nanosized colloidal particles with a 
hydrophobic core and hydrophilic shell, and they are currently successfully used 
as pharmaceutical carriers.7 Micelles are formed from amphiphilic block or graft 
copolymers when dissolved in selective solvent (in a concentration above their 
CMC), phenomenon first observed by Merret in 1954.8 Then, since Ringsdorf et al. 
publication,9 micelles where proposed and investigated for the last three decades 
as promising drug delivery systems for a broad variety of applications, especially 
in biomedical field. 7, 10, 11  
Typical advantages from the use of these self-assembled nanostructures in the 
nanomedicine field, are the possibility to obtain an elevated degree of 
encapsulation without chemical reactions of many macromolecule types, and 
their ability to reach the smallest capillary vessels and penetrate the tissues either 
through the paracellular or the transcellular pathways.12-15 
In this thesis, data from studies done on Hyaluronan based nanohydrogel and 
pNIPAAm based micelles are reported with emphasis on the synthetic strategies 
for polymers modification (in particular exploit by azido-alkyne click chemistry 
reaction) and their extensive characterization, nanostructures formulation and 
subsequent drugs loading capacity investigation.  
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Chapter 1 of the thesis provide a general introduction on the development of 
Nano Drug Delivery Systems (NDDS) such as polysaccharide based NHs and 
polymeric micelles, and their promising approach for developing intelligent 
therapeutic systems. In particular, Hyaluronan based NHs and thermosensitive 
poly(NIPAAm) based micelle were introduced. Moreover, riboflavin 2',3',4',5'- 
tetrabutyrate was introduced and used in this work, in order to provide the 
needed amphiphilic character of the chosen polymers necessary to provide the 
aimed self-assembled nanostructures. The use of Rfv in nanomedicine field indeed 
represent a promising alternative, due to its biocompatibility, low cost, versatile 
chemistry and specific transporter systems overexpressed in metabolically active 
cells. To the end, Copper(I)-catalyzed Azide-Alkyne Cycloaddition (CuAAC) 
reaction, well known as azido-alkyne click chemistry reaction, was mentioned as 
synthetic strategy used for the polymers modification. Generally, click chemistry 
reactions are modular, wide in scope, high yielding, create only inoffensive by-
products, stereospecific, simple to perform and that require benign or easily 
removed solvent.16 Finally, the aims of the thesis were outlined.  
 Nowadays, polysaccharide-based nanoparticles have been proposed for 
innovative NDDSs due to their unique multi-functional groups in addition to their 
physicochemical properties, in particular their marked biocompatibility and 
biodegradability.17 Among polysaccharides, hyaluronic acid (HA) seems to be one 
of the most interesting material for the development of biocompatible drug 
carriers. In Chapter 2, hyaluronan was chosen as representative of anionic 
polysaccharide, from which an amphiphilic polymer was obtained after 
conjugation of riboflavin tetrabutyrate (Rfv) as hydrophobic moiety, to form NHs 
by self-assembly. Different Mw of hyaluronan were first modified with a 
propargylic portion (Prop) suitable for the coupling on it of the azido-derivative of 
riboflavin (RfvN3) via azide-alkyne click chemistry reaction. In the chapter, all the 
synthetic strategies and the characterization techniques, in terms of degree of 
substitution (DS) obtained with the Prop and RfvN3 portions and in terms of the 
ability to form self-assembled NHs, are described and discussed. In particular, HA 
derivatization with propargylic portion was always a good strategy to easily 
modify the polymer chains and obtain a derivative in high yield and with a good 
derivatization degree.  
The coupling with RfvN3 by click chemistry, as expected, resulted in quantitative 
derivatization, due to the high efficacy and selectivity of this kind of reaction. 
Next, the HA-c-Rfv derivatives were tested with a new method to obtain NHs, i.e. 
the autoclaving process, to generate in one-step spontaneously sterile NHs by 
self-assembling of the polymer chains under thermal treatment.18  HA-c-Rfv NHs 
showed a good average size (depending on the Mw of HA derivative used and its 
DS with Prop and Rfv), low PDI and high stability in aqueous suspensions. Then, 
the nano-carrier ability to load by physical interaction hydrophobic model drugs 
was successfully tested. These NHs indeed have been used to solubilize piroxicam, 
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dexamethasone and paclitaxel resulting in an increase of their water solubility of 
12, 3 and 25-fold respectively. Moreover, in order to obtain a long-life preparation 
of NHs, a cryoprotectant solution (1 % w/V dextrose) was added to the drug-
loaded NHs before their storage for several months after freeze-drying, due to the 
fact that cryoprotection with sugars significantly enhanced the ability to re-
suspend nanoparticles after freeze-drying without aggregation. Lastly, with the 
aim to have a prolonged blood circulation of these nanostructures, a PEG-HA-c-
Rfv product was synthetized from HA-c-Rfv derivative that presented free 
propargylic moieties available for the click coupling of a PEG-N3, because 
PEGylation has recently been shown to dramatically improve particle transport 
through biological obstacles.  
   For polymeric micelles, a promising strategy to be successful in field of drug 
delivery the drug should be released only after it accumulates at the targeted 
tissue in a controlled manner by using i.e. stimulus responsive systems. 
Stimulation by either a physiological or an external trigger then results in the 
destabilization of micelles. An important class of stimuli-responsive micelles are 
those comprising polymers with thermosensitive behavior, of which the aqueous 
solution properties are temperature dependent.19 In chapter 3, thermosensitive 
polymeric micelles based on poly(N-isopropylacrylamide) (pNIPAAm) have been 
investigated. In particular, mPEG-b-p(NIPAAm)-co-AzEMA AB block-copolymer 
was synthesized by free radical polymerization using a polyethylene glycol based 
macroinitiator. Subsequently, a propargylic derivative of riboflavin 
tetratubutyrate (RfvProp) was conjugated by azido-alkyne click reaction as 
functional groups facilitating π-π stacking interactions to stabilize these micelles. 
The mPEG block is hydrophilic, while the p(NIPAAm) block is thermosensitive, and 
therefore when aqueous solutions of this polymer were heated from 4°C to above 
the LCST of the thermosensitive block, micelles were formed consisting in mPEG 
corona and p(NIPAAm)-AzEMA or p(NIPAAm)-AzEMA-Rfv core, respectively.  
Noteworthy,  Rfv contributed to an increase of the hydrophobicity of the polymer, 
resulting in reduction of the cloud point of the thermosensitive block (from 27°C 
for mPEG-b-p(NIPAAm)-co-AzEMA to  24°C for mPEG-b-p(NIPAAm)-co-AzEMA-
Rfv), and in less energy needed to dehydrate for the polymers during micelle 
formation.  The possibility of the Rfv framework to establish effective 
supramolecular interactions  with each other via its aromatic moieties was 
investigated by molecular modeling.  In general, the most stable dimeric adducts 
of Rfv are those displaying a parallel or T-shaped conformation of the aromatic 
planes.20 Based on the modeling experiments, some possible interactions were 
identified that may play a role in the generation of a complex micellar core system 
in which the tetra-esterified form of Rfv occupies a relatively large volume, 
resulting, in less dense structure of the core of the obtained micelle. In addition, 
the high value of polydispersity obtained for the mPEG-b-p(NIPAAm)-co-AzEMA-
Rfv derivative, can be attributed to the latent activity of the azido-groups, which 
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might suggest partial crosslinking of the polymer chains. Importantly, the poorly 
water-soluble anticancer drug paclitaxel (PTX) was successfully encapsulated into 
the micelles formed by these two synthesized polymers with a high loading 
efficiency, in particular higher for the mPEG-b-p(NIPAAm)-co-AzEMA-Rfv based 
micelle. PTX was however not retained for long periods of time in both types of 
micelles with a complete release within 24h. 
 
4.2 Perspectives  
   The development of two kinds of self-assembled nanocarriers, i.e. nanohydrogel 
and micelles, is presented in this thesis, and the shown results are promising for 
their application in nanomedicine therapies. Nevertheless, further optimization 
and research is necessary to take their development to reach clinical trials. Before 
the clinical application, detailed pharmacokinetic and biodistribution studies need 
to be performed as well as efficacy studies.  Moreover, improvement and more 
sophisticated chemical modification strategies for the polymers synthesis may 
enhance the preparation of well-defined polymers.  
 
4.2.1 Polymer design 
   In this thesis, the main synthetic strategy used for polymers modification was 
1,3-dipolar azide-alkyne cycloaddition reaction carried out under mild conditions 
using Cu(I) as the catalyst. Although copper catalysis has been widely employed to 
activate terminal alkynes in click chemistry, this may be incompatible with living 
systems due to toxicity of copper. Even though, in both the reaction strategies 
described in this thesis Cu+ ions were removed by work up of the products by 
ethylenediaminetetraacetic acid disodium salt dihydrate (EDTA) solution, enabling 
its chelating properties to coordinate the metal ions, that might bring, in our case, 
pure non-cytotoxic products . Moreover, recently severe cleavage of 
polysaccharide backbone have been reported after their derivatization by CuAAC 
reaction.21 The observed depolymerizaion was rationalized as being mediated by 
ROS agents formed from the oxidation of Cu(I) to Cu(II) by atmospheric oxygen. In 
this respect, in the presented strategies, the Cu(I) catalyst was prepared in situ by 
reducing copper(II) salts, such as CuSO4 5H2O, with a reducing agent, such as 
sodium ascorbate. This used method suppressed the formation of undesired 
byproducts associated with the use of Cu(I) and had the advantage of not 
requiring inert conditions to prevent the oxidation of Cu(I) to Cu(II) by 
atmospheric oxygen.  
However, a valid alternative may be the employment of highly strained cyclic 
alkynes that readily and selectively react with azides at ambient temperature and 
pressure, and do not need use of catalysts. In this way, the click chemistry 
products do not present apparent cytotoxicity.  
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This copper-free click chemistry reaction proposed by Codelli et al., presented a 
rate of the reaction comparable to that of the Cu(I)-catalyzed reaction, validating 
the potential of this strategy.22 In addition, Mock and co-workers established that 
the rate and regioselectivity of the azide-acetylene cycloaddition can be 
dramatically enhanced by sequestering the two components inside a host 
structure (i.e. enzymes), confirming the possibility of click chemistry in situ as 
further alternative to the Hüisgen reaction.23, 24 
   In addition, in order to develop systems for clinical evaluation, the materials 
used need to be well defined and pharmaceutically acceptable. The polymer 
described in chapter 3, mPEG-b-p(NIPAAm)-co-AzEMA, was synthetized by free 
radical polymerization. The main disadvantage of this polymerization strategy are 
the low control on the molecular weight and a broad molecular weight 
distribution as results of the strategy. ATRP (atom transfer radical polymerization) 
and RAFT (reversible addition-fragmentation chain transfer) polymerizations are 
most attractive in that sense, resulting in more control over polydispersity of the 
obtained products.25, 26 Moreover, azido-groups of the mPEG-b-p(NIPAAm)-co-
AzEMA-Rfv chains showed latent activity. In fact, other scientist reported that the 
azide group is able to form a highly reactive nitrene upon thermolysis or 
photolysis, which can then undergo a side reaction, resulting in crosslinking.27 
These side reactions can likely be limited to a certain extent by using lower 
monomer concentrations during polymerization or decreasing the polymerization 
reaction time. 
   In conclusion, improvement of the chemical modification strategies may result 
in well-defined polymers, which may result in monodisperse, smaller and more 
efficient nanocarriers.  
 
4.2.2 Biomedical application 
   The studies described in this thesis are mainly focused on the polymers design, 
characterization and nanostructures formulation. However, great progress can 
still be made in further developing these nanoparticles for biomedical application. 
As shown in the thesis, the use of natural molecules and polymers, such as 
riboflavin and hyaluronan, formed promising nanohydrogels that are expected to 
be biocompatible. However, before considering evaluation in vivo, in vitro 
cytotoxicity tests of both the developed systems need to confirm their 
biocompatibility. Moreover, due to the fluorescence properties of riboflavin, may 
facilitate the quantification of the amount of Rfv derivatives in the nanocarrier, 
and these NHs and micelles may be easily detected in biodistribution studies and 
may be applied for image guided drug delivery, which would allow following the 
destiny of the drug loaded nanocarriers in a real time and non-invasive manner. 
On this respect, preliminary studies of the fluorescence profile of riboflavin were 
carried out, even though its fluorescence quantum is dependent from solvent 
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polarity due to particular interactions between the molecule and the medium that 
can easily result in fluorescence quenching. Nevertheless, as already reported in 
literature,28 improvement of the experimental conditions related to the medium 
choice and appropriate concentration of the samples, may solve Rfv quenching 
phenomenon, reaching the goal of the mentioned study.  
   Moreover, overexpression of RCP (Riboflavin Carrier Protein) was found in 
tumor tissues, in particular in the cases of breast, prostate and hepatocellular 
carcinoma. For this purpose, it may be interesting to improve the design these 
nanocarriers, i.e. by attaching Rfv on the outside as targeting ligand for specific 
delivery of anticancer therapeutics to such tumors, even though the interactions 
between Rfv and cancer cells is quite complex and the regulative mechanisms is 
not well clarified yet. Last but not least, to simplify the core structure of the 
micelle developed in chapter 3, a non-esterified form of Rfv may be used in order 
to preserve the isoalloxazine ring to act as stabilizer of the micelle dispersion by π-
π stacking interactions, that may occupy less volume and may result in a more 
dense structure.  
   Finally, both the developed nanosystems have been shown that are likely 
suitable to load drugs that are characterized by an high hydrophobicity and have 
aromatic groups. Piroxicam and dexamethasone loaded-NHs may potentially 
benefit for arthritis treatment. Paclitaxel loaded-NHs and micelle may result a 
good strategy for cancer therapy.  On one hand, it would be possible to load 
multiple hydrophobic drugs/compounds to achieve synergistic effect. 
 
 
4.3 Conclusions  
   In conclusion, this thesis describes the development of two kinds of promising 
Nano Drug Delivery Systems: polysaccharide NHs and polymeric micelles, which 
both can be obtained by chemical tailoring of the composition and architecture of 
amphiphilic polymers. Their pharmaceutical formulations resulted be easy and 
occurred in nano-sizes carriers with long-term stability, that can potentially reach 
the smallest capillary vessels and penetrate the tissues. Moreover, the adopted 
physical entrapment of drugs in such nanocarriers might result in preservation of 
their activity and integrity to reach the desired area for a maximized therapeutic 
activity and minimized undesirable side effects. The mentioned aspects indeed 
encourage further investigations for their improved therapeutic performance.  
 
 
 
Summary and Perspectives 
129 
 
References 
(1) S. V. Vinogradov, E. V. Batrakova, A.V. Kabanov, Poly(ethylene glycol)-
polyethyleneimine NanoGel(TM) particles: Novel drug delivery systems for 
antisense oligonucleotides. Coll. Surf. B: Biointerfaces., 1999; 16: 291–304 
(2) P. Lemieux, S. V. Vinogradov, C. L. Gebhart, N. Guérin, G. Paradis, H. K. Nguyen, 
B. Ochietti, A. V. Kabanov, et al, Block and graft copolymers and NanoGel 
copolymer networks for DNA delivery into cell. J Drug Target., 2000; 8: 91-105 
(3) K. Akiyoshi, S. Deguchi, N. Moriguchi, S. Yamaguchi, J. Sunamoto, Self-
aggregates of hydrophobized polysaccharides in water. Formation and 
characteristics of nanoparticles. Macromolecules, 1993, 26: 3062–3068 
(4) Z. Y. Qian, S. Z. Fu and S. S. Feng, Nanohydrogels as a prospective member of 
the nanomedicine family. Nanomedicine, 2013, 8: 161–164 
(5) C. Gonçalves, P. Pereira and M. Gama, Self-Assembled Hydrogel Nanoparticles 
for Drug Delivery Applications. Materials, 2010, 3: 1420-1460 
(6) D. A Ossipov, Nanostructured hyaluronic acid-based materials for active 
delivery to cancer. Expert Opin. Drug Deliv., 2010, 7: 681-703 
(7) V. P. Torchilin, Micellar Nanocarriers: Pharmaceutical Perspectives. 
Pharmaceutical Research, 2007, 24 
(8) F. M. Merrett, The interaction of polymerizing systems with rubber and its 
homologues: part 2. –Interaction of the rubber in the polymerization of methyl 
methacrylate and of styrene. Transactions of the Faraday society, 1954, 50: 759-
767 
(9) H. Bader, H. Ringsdorf, B. Schmidt, Watersoluble polymers in medicine. Die 
Angewandte Makromolekulare Chemie, 1984, 123: 457–485 
(10) H. M. Aliabadi & A. Lavasanifar, Polymeric micelles for drug delivery. Expert 
Opinion on Drug Delivery, 2006, 3: 139-162 
(11) G. S. Kwon, M. Naito, K. Kataoka, M. Yokoyama, Y. Sakurai, T. Okano, Block 
copolymer micelles as vehicles for hydrophobic drugs. Colloids and Surfaces B: 
Biointerfaces, 1994, 2: 429-434 
(12) F. Sultana, Manirujjaman, Md. Imran-Ul-Haque, M. Arafat, S. Sharmin, An 
Overview of Nanogel Drug Delivery System. J. of App. Pharma. Sc., 2013, 3: 95-105 
(13) S. Rigogliuso, M. A. Sabatino, G. Adamo, N. Grimaldi, C. Dispenza and G. 
Ghersia, Polymeric Nanogels: Nanocarriers For Drug Delivery Application. Chem. 
Eng. Transactions, 2012, 27 
Chapter 4 
130 
 
(14) C. Gonçalves, P. Pereira and Mi. Gama, Self- Assembled Hydrogel 
Nanoparticles for Drug Delivery Applications. Materials, 2010, 3: 1420-1460 
(15) K. A. Wilk, K. Zieliñska, J. Pietkiewicz, J. Saczko, Loaded nanoparticles with 
cyanine-tipe photosensizers: preparation, characterization and encapsulation. 
Chem. Eng. Transactions, 2009, 17: 987-992 
(16) H. C. Kolb, M. G. Finn and K. B. Sharpless, Click Chemistry: Diverse Chemical 
Function from a Few Good Reactions. Angew Chem Int Ed Engl., 2001; 40: 2004-
2021 
(17) B. Kang, T. Opatz, K. Landfester, F.R. Wurm, Carbohydrate nanocarriers in 
biomedical applications: functionalization and construction. Chem. Soc. Rev., 
2015, 44: 8301–8325 
(18) E. Montanari, M. C. De Rugeriis, C. Di Meo, R. Censi, T. Coviello, F. Alhaique, 
P. Matricardi, One-step formation and sterilization of gellan and hyaluronan 
nanohydrogels using autoclave. J Mater Sci: Mater Med, 2015; 26: 32 
(19) P. Shao, B. Wang, Y. Wang, J. Li, and Y. Zhang, The Application of 
Thermosensitive Nanocarriers in Controlled Drug Delivery. J. of Nanomaterials, 
2011 
(20) H. Suzuki, R. Inoue, S. Kawamorita, N. Komiya, Y. Imada, and T. Naota; Highly 
Fluorescent Flavins: Rational Molecular Design for Quenching Protection Based on 
Repulsive and Attractive Control of Molecular Alignment. Chem. Eur. J. 2015; 21: 
9171 – 9178 
(21) E. Lallana, E. Fernandez-Megia, and R. Riguera, Surpassing the Use of Copper 
in the Click Functionalization of Polymeric Nanostructures: A Strain-Promoted 
Approach. J. Am. Chem. Soc., 2009, 1311: 5748–5750 
(22) J. A. Codelli, J. M. Baskin, N. J.  Agard, et al. Second-generation difluorinated 
cyclooctynes for copper-free click chemistry. J Am Chem Soc, 2008; 130: 11486 
(23) W. L. Mock, T. A. Irra, J. P. Wepsiec, T. L. Manimaran, Cycloaddition induced 
by cucurbituril. A case of Pauling principle catalysis. J. Org. Chem., 1983, 48, 3619–
3620 
(24) W. G. Lewis, L. G. Green, F. Grynszpan, Z. Radic, P. R. Carlier, P. Taylor, M. G. 
Finn, and K. Barry Sharpless, Click Chemistry In Situ: Acetylcholinesterase as a 
Reaction Vessel for the Selective Assemblym of a Femtomolar Inhibitor from an 
Array of Building Blocks. Angew. Chem. Int. Ed., 2002, 41: 1053-1057 
(25) G. Moad, E. Rizzardo, S. H. Thang, Living radical polymerization by the RAFT 
process-A firs update. Australian Journal of Chemistry, 2006, 59: 669-692 
Summary and Perspectives 
131 
 
(26) K. Matyjaszewski, J. Xia, Atom transfer radical polymerization. Chem. Rev., 
2001, 101: 2921-2990 
(27) Y. Li, J. Yang, B. C. Benicewicz, Well-Controlled Polymerization of 2-Azidoethyl 
Methacrylate at Near Room Temperature and Click Functionalization. J. of Pol. Sc.: 
Part A: Pol. Chem., 2007, 45: 4300–4308 
(28) P. F. Heelis, The photophysical and photochemical properties of flavins 
(isoalloxazines). Chem. Soc. Rev., 1982, 11: 15-39  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
Chapter 4 
132 
 
 
Acknowledgment 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
First, I would like to thank my advisors Dr. Pietro Matricardi and Dr. Chiara Di Meo 
for offering me the possibility to work in their group and guide me in this research. 
It is my pleasure to express my gratitude to Prof. Tommasina Coviello and Prof. 
Franco Alhaique for their special help, support and wide knowledge. 
 
I would like to thanks once again Prof. Marco Pierini for his support and precious 
(scientific and non) suggestions…again, anyway.  
 
I express my gratitude to Prof. Wim Hennink and Dr. Tina Vermonden for providing 
me with the opportunity to spend the last 18 months of my PhD at the Utrecht 
University as external PhD visiting.  
 
My deeper gratitude is obviously extended to my family and my friends.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
